                                 NBER WORKING PAPER SERIES




                              HEALING THE POOR:
THE INFLUENCE OF PATIENT SOCIOECONOMIC STATUS ON PHYSICIAN SUPPLY RESPONSES

                                              Alice Chen
                                         Darius N. Lakdawalla

                                         Working Paper 21930
                                 http://www.nber.org/papers/w21930


                        NATIONAL BUREAU OF ECONOMIC RESEARCH
                                 1050 Massachusetts Avenue
                                    Cambridge, MA 02138
                             January 2016, Revised February 2019




   Previously circulated as "Saving Lives or Saving Money? Understanding the Dual Nature of
   Physician Preferences." We gratefully acknowledge comments from Joshua Gottlieb and other
   participants at the American Economic Association Annual Meeting, the BU-Harvard-MIT
   Health Seminar, the NBER Health Care Summer Institute, the Midwest Health Economics
   Seminar, and the USC CESR-Schaeffer Brown Bag. Research reported here was supported by the
   National Institute on Aging of the National Institutes of Health under award number
   P01AG033559 and P30AG024968. The content is solely the responsibility of the authors and
   does not necessarily represent the official views of the National Institutes of Health or the
   National Bureau of Economic Research

   At least one co-author has disclosed a financial relationship of potential relevance for this
   research. Further information is available online at http://www.nber.org/papers/w21930.ack

   NBER working papers are circulated for discussion and comment purposes. They have not been
   peer-reviewed or been subject to the review by the NBER Board of Directors that accompanies
   official NBER publications.

   Â© 2016 by Alice Chen and Darius N. Lakdawalla. All rights reserved. Short sections of text, not
   to exceed two paragraphs, may be quoted without explicit permission provided that full credit,
   including Â© notice, is given to the source.
Healing the Poor: The Influence of Patient Socioeconomic Status on Physician Supply Responses
Alice Chen and Darius N. Lakdawalla
NBER Working Paper No. 21930
January 2016, Revised February 2019
JEL No. I11,I12,I18

                                         ABSTRACT

A longstanding literature explores how altruism affects the way physicians respond to incentives
and provide care. We analyze how patient socioeconomic status mediates these responses. We
show theoretically that patient socioeconomic status systematically influences the way physicians
respond to reimbursement changes, and we identify the channels through which these effects
operate. We use two Medicare reimbursement changes to investigate these insights empirically.
We confirm that a given physician facing an increase in reimbursement boosts utilization by more
when treating richer patients. We show that average supply price elasticities vary from 0.02 to
0.18 for a given physician, depending on the patientâ€™s socioeconomic status. Finally, we show
that the Medicare reforms we study led to overall reimbursement increases that raised healthcare
utilization by 10% more for high-income patients compared to their low-income peers.


Alice Chen
Schaeffer Center for Health Policy and Economics
University of Southern California
635 Downey Way
Los Angeles, CA 90089-3333
alicejc@usc.edu

Darius N. Lakdawalla
University of Southern California
635 Downey Way, VPD 414-K
Schaeffer Center for Health Policy and Economics
Los Angeles, CA 90089-7273
and NBER
dlakdawa@usc.edu
1. Introduction

       Economists have long emphasized the peculiarities of healthcare markets, compared to
other markets for goods and services. Since at least Kenneth Arrowâ€™s pioneering paper on the
subject, economists have recognized two features in particular: the altruism of healthcare providers
towards their patients and the reliance of patients on their physicians for information and guidance
(Arrow 1963).
       Altruism encourages physicians to faithfully represent their patientsâ€™ interests. An altruistic
physician will tend to economize on the use of scarce inputs and attempt to improve the well-being
of her patients. On the other hand, the informational advantage of physicians creates a classic
agency problem that physicians might exploit to pursue their own interests at the expense of their
patientsâ€™ (for example, Dranove and White 1987; Blomqvist 2002; Emanuel and Emanuel 1992;
Mooney and Ryan 1993; Zweifel, Breyer, and Kifmann 1997). These countervailing incentives
produce conflicting implications for pricing. Self-interested physicians will respond to higher
prices by performing more procedures. Altruistic physicians, on the other hand, will protect their
patients from higher prices by performing fewer procedures. Prior literature has investigated these
complex implications of physician altruism on a variety of outcomes, including physician labor
supply, patient health, patient treatment plans, responses to reimbursement changes, optimal
insurance design, and quality of care (Chone and Ma 2011; Clemens and Gottlieb 2014; Dickstein
2016; Dranove 1988; Ellis and McGuire 1990; Ellis and McGuire 1986; Godager and Wiesen
2013; Jack 2005; Jacobson et al. 2017; Liu and Ma 2013; McGuire 2000; Rochaix 1989; Glied and
Zivin 2002).
       Less attention has been paid to the influence of patient socioeconomic status on physician
decision making. Intuitively, if physicians care about patient utility, then factors that affect
marginal utilityâ€“ such as patient wealth and incomeâ€“ might systematically alter how a physician
behaves, even for otherwise clinically similar patients. Figure 1 offers some suggestive evidence
of what this might mean empirically.

                                       [Insert Figure 1 Here]

       The figure reports a weighted price index over time for Medicare, alongside an index of
utilization by high-income and low-income patients. The price index measures the average change


                                                     2
in reimbursements for a fixed basket of procedures that are weighted by the intensity required to
perform them. In the wake of rapid acceleration in prices, the utilization of high-income patients
appeared to rise more rapidly than that of their low-income counterparts.
       In this paper, we investigate theoretically and empirically how patient socioeconomic
status influences altruistic physicians facing reimbursement changes. We rely on well-established
models of physician behavior to explore how patient socioeconomic status influences physicians
when patients face positive cost-sharing. We demonstrate theoretically that there are two
components to the effect of socioeconomic status. First, when utilization is held fixed across all
patients, physiciansâ€™ supply response to higher reimbursements will be larger (i.e., more positive)
for richer patients. Richer patients face lower marginal disutility of price increases because of their
higher incomes. Thus, on the margin, it is less costly for altruistic physicians to â€œharvestâ€ higher
utilization from these patients. Second, however, differences in utilization across richer and poorer
patients always give rise to a countervailing â€œutilization effectâ€ that we elucidate theoretically.
Thus, economic theory predicts that the same physician might respond differently to a price change
when treating a richer patient, even holding clinical considerations fixed. The direction of the effect
becomes an empirical question of interest.
       Empirically, we estimate the effect of patient socioeconomic status on physician supply
responses by using two exogenous policy shocks to Medicare payments: the 1997 consolidation
of geographic payment regions and the 1999 change in estimation of practice expenses. Our results
indicate that a given physicianâ€™s supply response is stronger when she treats richer patients.
Moreover, the variation in price elasticities matters quantitatively. Within physicians, average
price elasticities vary from 0.02 to as high as 0.18, when treating patients in the bottom or top
socioeconomic status deciles, respectively. Finally, we estimate that our two exogenous policy
shocks increased utilization among high-income patients by 10% more than among low-income
patients. This effect accounts for about 53% of the divergence across income groups that we see
in Figure 1.
       The rest of the paper is organized as follows. In Section 2, we investigate the theoretical
relationship between patient socioeconomic status and physician supply responses. In Section 3,
we discuss the empirical approach for estimating the effects of socioeconomic status on supply
responses. In Section 4, we present the empirical results, and Section 5 concludes.



                                                      3
2. Theoretical Framework

           We study how variation in patient socioeconomic status influences the way altruistic
physicians respond to price. We rely on a simple and stylized model of altruistic decision making
that dates back to Becker (1957). The model has been used by many health economists before us
to study physician behavior (cf, Clemens and Gottlieb 2014; Ellis and McGuire 1986; Ellis and
McGuire 1990; McGuire 2000; McGuire and Pauly 1991; Dickstein 2016).
           Consider the treatment of a particular patient by a particular physician. 1 The physician
produces health in the patient according to the strictly concave function ğ¹ğ¹(ğ‘‹ğ‘‹), where ğ‘‹ğ‘‹ is the level
of medical care used. We focus on the case where the patient is exposed to some degree of cost-
sharing for care because we are interested in how physicians respond when price changes directly
impact patient utility. The patient pays ğœğœ(ğ‘‹ğ‘‹; ğ‘ƒğ‘ƒ) for ğ‘‹ğ‘‹ amount of medical care, where ğ‘ƒğ‘ƒ is the price
for medical care received by the physician, and ğœğœ is the cost-sharing function that defines the
patientâ€™s out-of-pocket cost. Denoting partial derivatives with subscripts, we assume that ğœğœğ‘ƒğ‘ƒ >
0, ğœğœğ‘‹ğ‘‹ > 0, and ğœğœğ‘‹ğ‘‹ğ‘‹ğ‘‹ > 0. In addition, we also assume ğœğœğ‘‹ğ‘‹ğ‘‹ğ‘‹ = 0, which rules out nonlinear cost-
sharing arrangements. Coinsurance that asks patients to pay a fixed percentage of cost would
satisfy all these assumptions. Finally, define the patientâ€™s burden of all other medical care spending
as ğœ‹ğœ‹; this includes health insurance premiums and out-of-pocket spending on care given by
providers other than this particular physician. Assume the representative patient derives strictly
concave utility from consumption according to ğ‘¢ğ‘¢(ğ¼ğ¼ + ğ‘£ğ‘£ğ‘£ğ‘£(ğ‘‹ğ‘‹) âˆ’ ğœğœ(ğ‘‹ğ‘‹; ğ‘ƒğ‘ƒ) âˆ’ ğœ‹ğœ‹). ğ¼ğ¼ is income, ğ‘£ğ‘£ is the
value of health, and both are measured in units of the same numeraire consumption good.
           All medical decisions are made by the physician. This is a stylized assumption that helps
focus on the incentives of the physician and motivate our empirical analysis of physician price-
responses. The physician cares about her own utility and that of the patient, according to:
                          max(1 âˆ’ ğ›¼ğ›¼)ğ‘§ğ‘§ï¿½ğ‘ƒğ‘ƒğ‘ƒğ‘ƒ âˆ’ ğ‘ğ‘(ğ‘‹ğ‘‹)ï¿½ + ğ›¼ğ›¼ğ›¼ğ›¼ï¿½ğ¼ğ¼ + ğ‘£ğ‘£ğ‘£ğ‘£(ğ‘‹ğ‘‹) âˆ’ ğœ‹ğœ‹ âˆ’ ğœğœ(ğ‘‹ğ‘‹; ğ‘ƒğ‘ƒ)ï¿½.                                               (1)
                             ğ‘‹ğ‘‹

           The function ğ‘ğ‘(â‹…) is the physicianâ€™s strictly convex cost of providing medical care, and the
function ğ‘§ğ‘§(â‹…) is her weakly concave utility from her own income. The degree of altruism towards
the patient is ğ›¼ğ›¼. The first-order condition for medical care utilization can be written as:


           1
             Prior to physician service provision, patientsâ€”in theoryâ€”choose their provider. Patient choice of physician, while quite an interesting
problem, lies beyond the scope of our paper. We address its implications for our empirical analysis in Sections 3 and 4.



                                                                              4
                                         ğ›¼ğ›¼ğ‘¢ğ‘¢â€² âˆ— (ğ‘£ğ‘£ğ‘£ğ‘£â€² âˆ’ ğœğœğ‘‹ğ‘‹ ) + (1 âˆ’ ğ›¼ğ›¼)ğ‘§ğ‘§ â€² âˆ— (ğ‘ƒğ‘ƒ âˆ’ ğ‘ğ‘â€²) = 0                                                     (2)
           Notice that either ğ‘£ğ‘£ğ‘£ğ‘£â€² âˆ’ ğœğœğ‘‹ğ‘‹ < 0 or ğ‘ƒğ‘ƒ âˆ’ ğ‘ğ‘â€² < 0. 2 Therefore, medical care is strictly costly
on the margin to either the consumer or the physician, respectively, but never both. Figure 2 depicts
the conditions that determine which case prevails. When ğ‘£ğ‘£ğ‘£ğ‘£â€² intersects ğœğœğ‘‹ğ‘‹ before ğ‘ğ‘â€² intersects ğ‘ƒğ‘ƒ,
we end up with the case ğ‘£ğ‘£ğ‘£ğ‘£â€² âˆ’ ğœğœğ‘‹ğ‘‹ < 0, where care is costly to the consumer on the margin. This
corresponds to the left-hand panel of the figure (plot a), where ğ‘‹ğ‘‹ğ¹ğ¹ < ğ‘‹ğ‘‹ğ¶ğ¶ . Conversely, the opposite
case obtains when ğ‘‹ğ‘‹ğ¹ğ¹ > ğ‘‹ğ‘‹ğ¶ğ¶ (plot b).

                                                            [Insert Figure 2 Here]

           From the patientâ€™s perspective, ğ‘£ğ‘£ğ‘£ğ‘£â€² âˆ’ ğœğœğ‘‹ğ‘‹ < 0 implies â€œprivate under-useâ€ of medical care
in the sense that more utilization at the equilibrium point would increase her utility. Private under-
use is possible in this setting because patients do not directly decide on medical care. Physicians
make these decisions, and they will fail to choose the patientâ€™s privately optimal utilization level
unless they are perfectly altruistic. For notational convenience, we refer to ğ‘£ğ‘£ğ‘£ğ‘£â€² âˆ’ ğœğœğ‘‹ğ‘‹ < 0 as the
case of â€œprivate over-useâ€ and to ğ‘£ğ‘£ğ‘£ğ‘£â€² âˆ’ ğœğœğ‘‹ğ‘‹ > 0 as the case of â€œprivate under-use.â€ For clarity,
these cases do not represent social under-use or over-use, but rather over-use and under-use from
the patientâ€™s private perspective. All else equal, private over-use is more likely when: marginal
value product diminishes more quickly, marginal cost of medical care diminishes more slowly,
patient out-of-pocket prices are higher, or physician reimbursements are lower.

2.1. Effect of price and income on utilization

           Higher prices can either increase or decrease utilization depending on four distinct and
potentially offsetting forces that we will characterize. Differentiating Equation (2) with respect to
price results in:
                                 ğœ•ğœ•ğœ•ğœ•       ï¿½âˆ’ğ›¼ğ›¼ğ‘¢ğ‘¢â€² ğœğœğ‘‹ğ‘‹ğ‘‹ğ‘‹ âˆ’ğ›¼ğ›¼ğ‘¢ğ‘¢â€²â€² ï¿½ğ‘£ğ‘£ğ¹ğ¹â€² âˆ’ğœğœğ‘‹ğ‘‹ ï¿½(ğœğœğ‘ƒğ‘ƒ )+(1âˆ’ğ›¼ğ›¼)ğ‘§ğ‘§ â€² +(1âˆ’ğ›¼ğ›¼)ğ‘§ğ‘§ â€²â€² ï¿½ğ‘ƒğ‘ƒâˆ’ğ‘ğ‘ â€² ï¿½ğ‘‹ğ‘‹ï¿½
                                 ğœ•ğœ•ğœ•ğœ•
                                        =                                        (âˆ’ğ·ğ·)
                                                                                                                                                     (3)




           2
             In theory, there is a knife-edge case where ğ‘£ğ‘£ğ‘£ğ‘£â€² âˆ’ ğœğœğ‘‹ğ‘‹ = ğ‘ƒğ‘ƒ âˆ’ ğ‘ğ‘â€² = 0 is satisfied for a given value of ğ‘‹ğ‘‹. It is worth noting that a private
payer may in some special cases have incentives to design insurance benefits such that total surplus is maximized, and this condition holds. However,
we treat benefit design as exogenous, as it would be in public insurance. With exogenous benefit design, this is a rather idiosyncratic case that
depends entirely on functional form. We abstract from it.


                                                                                     5
          The denominator is positive, because the second-order condition implies ğ·ğ· â‰¡
ğ›¼ğ›¼ğ‘¢ğ‘¢â€²â€² (ğ‘£ğ‘£ğ¹ğ¹ â€² âˆ’ ğœğœğ‘‹ğ‘‹ )2 + ğ›¼ğ›¼ğ‘¢ğ‘¢â€² (ğ‘£ğ‘£ğ¹ğ¹ â€²â€² ) + (1 âˆ’ ğ›¼ğ›¼)ğ‘§ğ‘§ â€²â€² (ğ‘ƒğ‘ƒ âˆ’ ğ‘ğ‘ â€² )2 + (1 âˆ’ ğ›¼ğ›¼)ğ‘§ğ‘§ â€² (âˆ’ğ‘ğ‘ â€²â€² ) < 0. The sign of the
comparative static expression depends on the interplay among four distinct and countervailing
forces.
    1. â€œProfitability effectâ€ leads to higher output: Higher prices raise the physicianâ€™s marginal
          financial return to providing care, because (1 âˆ’ ğ›¼ğ›¼)ğ‘§ğ‘§ â€² > 0.
    2. â€œSubstitution effectâ€ leads to lower output: Higher prices induce a substitution effect
          that makes medical care more expensive for the patient, all else equal; an altruistic
          physician cuts output in response, because (âˆ’ğ›¼ğ›¼ğ‘¢ğ‘¢â€² ğœğœğ‘‹ğ‘‹ğ‘‹ğ‘‹ ) < 0.
    3. â€œPatient income effectâ€ leads to lower or higher output: Higher prices make the patient
          poorer, and this encourages the physician to transfer additional â€œnet consumptionâ€ to the
          patient. In the private over-use case, the physician cuts medical care utilization to
          accomplish this, because (âˆ’ğ›¼ğ›¼ğ‘¢ğ‘¢â€²â€² (ğ‘£ğ‘£ğ¹ğ¹ â€² âˆ’ ğœğœğ‘‹ğ‘‹ )(ğœğœğ‘ƒğ‘ƒ )) < 0. In the private under-use case, she
          raises medical care utilization to achieve the same end.
    4. â€œPhysician income effectâ€ leads to lower or higher output: Higher prices make the
          physician richer, and this encourages her to transfer additional â€œnet consumptionâ€ to the
          patient. In the private over-use case, the physician (weakly) cuts medical care utilization to
          accomplish this, because (1 âˆ’ ğ›¼ğ›¼)ğ‘§ğ‘§ â€²â€² (ğ‘ƒğ‘ƒ âˆ’ ğ‘ğ‘â€²)ğ‘‹ğ‘‹ â‰¤ 0. In the private under-use case, the
          opposite occurs. Note this effect disappears when the physicianâ€™s objective function is
          quasi-linear in her own income, a case we explore in more detail below.
                                                                                             ğœ•ğœ•ğœ•ğœ•
In principle, price increases can either increase or decrease utilization. When ğœ•ğœ•ğœ•ğœ• > 0, we can think

of supply as â€œphysician-drivenâ€ in the sense that physician preferences for profit dominate in the
                                                        ğœ•ğœ•ğœ•ğœ•
sign of the supply response. Conversely, when ğœ•ğœ•ğœ•ğœ• < 0, we can think of it as â€œpatient-driven,â€ since

patientsâ€™ downward-sloping demand for care dominates in the sign of this response.
          The effect of patient income on prices is analogous to the â€œpatient income effectsâ€
described above. In the case of private over-use, physicians will cut utilization when patients are
poorer, in an effort to make them better off. However, with private under-use, physicians will
actually raise utilization for poorer patients to accomplish the same objective. These results
become evident in another comparative static expression that follows from the first-order
condition:


                                                               6
                                           ğœ•ğœ•ğœ•ğœ•       ï¿½ğ›¼ğ›¼ğ‘¢ğ‘¢â€²â€² ï¿½ğ‘£ğ‘£ğ¹ğ¹â€² âˆ’ğœğœğ‘‹ğ‘‹ ï¿½ï¿½
                                           ğœ•ğœ•ğœ•ğœ•
                                                  =          (âˆ’ğ·ğ·)
                                                                                                      (4)

        This expression possesses a sign opposite to that of ğ‘£ğ‘£ğ‘£ğ‘£â€² âˆ’ ğœğœğ‘‹ğ‘‹ . This implies that patient
income will raise utilization in the case of private under-use but lower it when there is private over-
use.

2.2. Effect of income on physician supply response

        We are particularly interested in how patient income influences the supply response of
                         ğœ•ğœ•2 ğ‘‹ğ‘‹                                                        ğœ•ğœ•ğœ•ğœ•
physicians â€“ that is, in ğœ•ğœ•ğœ•ğœ•ğœ•ğœ•ğœ•ğœ•, the derivative of the comparative static expression ğœ•ğœ•ğœ•ğœ• with respect to

income. Intuitively, there are at least two countervailing forces that govern the effect of patient
income on physician supply response. The first is the direct effect of income, which reduces the
marginal disutility of price increases (âˆ’ğ›¼ğ›¼ğ‘¢ğ‘¢â€² ğœğœğ‘‹ğ‘‹ğ‘‹ğ‘‹ ). Since richer patients have lower marginal utility
of wealth, price increases are less harmful to their welfare. Thus, physicians are more willing to
harvest higher utilization (and earnings) from these patients when reimbursements increase. When
reimbursements increase by a fixed amount, therefore, physicians raise quantity by more when
they are treating richer patients.
        However, differences in utilization levels across income groups offset this direct income
effect. The â€œutilization level effectâ€ results in lower physician supply responses for richer patients.
This effect is more nuanced than the direct income effect. We illustrate its mechanics for both the
private over-use and under-use cases.
        Start by considering the case of private over-use. In this case, medical care is costly on the
margin to consumers. As a result, physicians find it optimal to provide more care to richer patients,
who can better afford it. However, at higher levels of utilization, physician supply responses
diminish. This obtains because patients with higher utilization suffer more harm from a given price
increase; this is analogous to Shepardâ€™s Lemma in consumer theory. Thus, an altruistic physician
â€œprotectsâ€ her richer, higher utilization patients by limiting her supply responses. Note that this
variability in physician response does not result from variability in the altruism parameter. Even if
physician preferences for altruistic behavior are exogenous and fixed, a single physician may
choose to behave differently towards clinically similar patients if they differ on socioeconomic
dimensions.



                                                                  7
       The case of private under-use leads to the same qualitative result, although it proceeds a
bit differently. Since medical care is valuable (not costly) to consumers on the margin, an increase
in medical care utilization functions like an increase in consumption. For this reason, physicians
provide more care to poorer patients, because they face a higher marginal utility of consumption.
Moreover, in this case, higher levels of utilization magnify physician supply responses; this
relationship is the reverse of what we see in the â€œprivate over-useâ€ case and is akin to Shepardâ€™s
Lemma for a good with a negative price. The net result is that physicians limit supply responses
for richer patients because they use less medical care.

                                       [Insert Figure 3 Here]

       Figure 3 summarizes these results graphically. The figure shows how the price-utilization
curve shifts and changes its slope with income. It depicts two levels of income, ğ¼ğ¼1 > ğ¼ğ¼0 , and two
levels of utilization, ğ‘‹ğ‘‹1 > ğ‘‹ğ‘‹0 . The left-hand panel illustrates the case of private over-use, where
higher income leads to more utilization at the same price level. Holding utilization constant at
either ğ‘‹ğ‘‹0 or ğ‘‹ğ‘‹1, when income goes up, the physician supply response strengthens in the sense that
the price-utilization curve attains a more steeply positive slope. However, holding income constant
and traveling along a given price-utilization curve, higher utilization limits the physician supply
response. Thus, moving from point A to point B always results in a stronger, more positive, supply
response, but the movement to point C might offset part or all of this change.
       The right-hand panel illustrates the alternative case of private under-use, where higher
income leads to less utilization at the same price level. Holding utilization constant, when income
goes up, the supply response once again strengthens. At the same time, when we travel along a
price-utilization curve, higher utilization leads to a smaller supply response. The net result is the
same as it was in the earlier case: moving from point A to point B (i.e., holding utilization constant)
results in a stronger supply response, but moving to point C produces an offsetting effect.
       We now formalize these intuitive arguments. Since we are studying changes in a
comparative static expression, it is necessary to impose structure on the third derivatives in the
problem. We follow the conventional strategy of considering objective functions that can be
approximated by quadratic polynomials (Becker and Murphy 1988; Chew, Epstein, and Segal
1991; Evans and Viscusi 1993; Finkelstein, Luttmer, and Notowidigdo 2013; Lillard and Weiss
1997). In particular, we impose the additional restrictions that ğ‘¢ğ‘¢â€²â€²â€², ğ¹ğ¹â€²â€²â€², and ğ‘ğ‘â€²â€²â€² are zero. In

                                                      8
addition, we assume the physicianâ€™s objective function is linear in her own income â€“ i.e., ğ‘§ğ‘§ is linear
(Clemens and Gottlieb 2014). These conditions allow us to draw specific conclusions about how
patient income influences physician supply response.

               Proposition 1: Assume that ğ‘ˆğ‘ˆ and ğ¹ğ¹ are strictly concave, ğ‘§ğ‘§ is linear,
              ğœğœğ‘‹ğ‘‹ , ğœğœğ‘ƒğ‘ƒ , ğœğœğ‘‹ğ‘‹ğ‘‹ğ‘‹ > 0, and ğ‘¢ğ‘¢â€²â€²â€² = ğ¹ğ¹â€²â€²â€² = ğ‘ğ‘â€²â€²â€² = ğœğœğ‘‹ğ‘‹ğ‘‹ğ‘‹ = 0. At equilibrium utilization ğ‘‹ğ‘‹ âˆ— ,
                 ğœ•ğœ•ğœ•ğœ•                   ğœ•ğœ•2 ğ‘‹ğ‘‹                         ğœ•ğœ•2 ğ‘‹ğ‘‹    ğœ•ğœ•2 ğ‘‹ğ‘‹
              if ğœ•ğœ•ğœ•ğœ• > 0, then ğœ•ğœ•ğœ•ğœ•ğœ•ğœ•ğœ•ğœ•ï¿½                  > 0 and ğœ•ğœ•ğœ•ğœ•ğœ•ğœ•ğœ•ğœ• < ğœ•ğœ•ğœ•ğœ•ğœ•ğœ•ğœ•ğœ•ï¿½ âˆ— .
                                                    ğ‘‹ğ‘‹ âˆ—                                  ğ‘‹ğ‘‹


           This proposition implies that, for fixed ğ‘‹ğ‘‹, increases in patient income strengthen physician
                                                                                                                                                   ğœ•ğœ•ğœ•ğœ•
supply responses in the empirically salient case of physician-driven price responses, where ğœ•ğœ•ğœ•ğœ• >

0. 3 However, variation in ğ‘‹ğ‘‹ across income groups mitigates this result.
           Variation in utilization (X) mitigates the relationship between patient income and physician
supply. In the case of private under-use, more income leads to less medical care utilization. Lower
utilization levels drive up marginal utility for richer patients and encourage the physician to
steward the patientâ€™s resources more carefully. On the other hand, in the case of private over-use,
more income leads to more medical care utilization. Since medical care is overused, growth in
medical care utilization caused by higher incomes will drive up the patientâ€™s marginal utility. This
limits physician supply responses. Therefore, income will strengthen supply responses by less
when medical care is allowed to vary, than it does when medical care is held fixed. We provide a
detailed proof of this proposition in Appendix A.

3. Empirical Analysis

           An important feature of the theory is the possibility that the same physician may respond
differently to the same price change, depending solely on the socioeconomic status of the patient
being treated. Thus, we wish to assess whether the same physician responds to price changes
differently when treating patients of different types. Alternative theories featuring backward-
bending supply curves or administratively set prices cannot readily explain why the same physician
would exhibit different supply responses simply when treating patients from different


             3
               Prior studies by Clemens and Gottlieb (2014), Gruber (2013), and Jacobson et al. (2017) find that the average effect of price on
utilization in Medicare is positive, and our empirical analysis presented later confirms this as well. Nonetheless, it is worth noting that if the opposite
                                         âˆ‚2 X
result obtains, we can no longer sign           ï¿½    unambiguously.
                                        âˆ‚P âˆ‚I Xâˆ—


                                                                                      9
socioeconomic groups. Our goal is not to rule out these other theories, but rather to â€œrule inâ€ ours.
Multiple theories could be (and likely are) at work in parallel within the marketplace.
                                                                                                         ğœ•ğœ•ğœ•ğœ•
             As illustrated in Figure 3, our theory demonstrates how                                     ğœ•ğœ•ğœ•ğœ•
                                                                                                                may vary with patient

socioeconomic status. The direction of the effect is an empirical question of interest. We estimate
ğœ•ğœ•2 ğ‘‹ğ‘‹
ğœ•ğœ•ğœ•ğœ•ğœ•ğœ•ğ¼ğ¼
           using several different measures of patient income. It is worth noting that our reduced form

approach allows us to estimate price responses while holding price constant (i.e., movement from
point A to point C in Figure 3). However, without a method for identifying a complete structural
model, we will not be able to simultaneously identify how price responses compare when holding
utilization constant (i.e., movement from point A to point B in Figure 3). Instead, we estimate the
total effect of socioeconomic status on price and leave structural estimation to future research.

3.1. Data

             To explore our hypotheses, we rely on data from 1993 to 2002 from the Medicare Current
Beneficiary Survey (MCBS). The MCBS is a nationally representative dataset that follows
approximately 11,500 Medicare beneficiaries per year, over four-year panels. It consists of both
administrative payment files and patient surveys, and this linkage between claims and survey data
makes the MCBS uniquely suitable for addressing our research question.
             The administrative files provide information on the fee-for-service Physician/Supplier Part
B claims. Each service provided is identified by a Healthcare Common Procedure Coding System
(HCPCS) code. These identifiers allow us to track individual physicians over time. We focus
entirely on physicians providing medical services and procedures (i.e., Level 1 HCPCS codes). 4
The patient surveys provide us with a rich set of covariates that allow us to identify patient
socioeconomic statuses. We consider two proxies for socioeconomic status: (1) patient incomeâ€”
which includes information on pre-tax wages, Social and Supplemental Security Income, pensions,
retirement income, interest from mutual funds and stocks, and other sources, and (2) the patientâ€™s
highest level of educational attainment.
             According to the theory, physician supply response will be affected by patient
socioeconomic status for a given medical service. Although the MCBS data does not provide


           4 We exclude Level II HCPCS codes, which are used primarily to identify supplies and products, such as durable medical equipment.
Additionally, we use the specialty code to exclude suppliers and providers in specialties which do not require an MD or DO degree (e.g., optometry,
physical therapists, social workers, nurses, etc.).

                                                                             10
sufficient variation for an analysis at the physician-patient-service level over time, we aggregate
individual HCPCS codes to their corresponding Berenson-Eggers Type of Service (BETOS) code.
BETOS codes consist of readily understood clinical categories that are relatively stable over time,
and the categories include evaluation and management services, imaging and tests, major
procedures, minor procedures, and all other procedures. This aggregation allows the supply
response to differ across types of procedures for a given physician-patient encounter.
           To obtain an accurate measure of prices that physicians face over time, we create a price
index for each physician-BETOS pair. Specifically, for each physician, we identify the universe
of procedures that she performs throughout our data period. The physicianâ€™s BETOS-specific price
index in a given year is the weighted sum of the Medicare allowed charges for her basket of
procedures within each BETOS code. The weights are constant over time, and they reflect the
share of total relative value units (RVUs)â€”capturing differences in the time, skill training, and
costs required to perform a procedureâ€”associated with a procedure. 5 Data on RVUs associated
with each HCPCS are identified from the Federal Registers in 1993 to 2002. The price indices are
inflation-adjusted to 2000$.
           On average, the evaluation and management BETOS category consisted of 2.8 different
HCPCS per physician, the imaging and tests category consisted of 5.6 different HCPCS per
physician, and the major and minor procedures consisted of 1.8 and 2.4 different HCPCS per
physician, respectively.

                                                        [Insert Table 1 Here]

           Table 1 shows summary statistics by patients with below-median income (Columns 1 and
2) and above-median income (Columns 3 and 4). For the low-income group, the mean annual
income (in 2000$) is roughly $8,575 and the average patient has 10 years of education. In contrast,
the mean annual income in the high-income group is $36,987 and patients have on average 12.75
years of education. 6 Relative to the low-income group, the group of high-income patients consists
of more married, White, non-Hispanic men. While patients in the high-income group use fewer
RVUs, they have a higher price index.


          5
            The RVU-weights come from summing work, practice, and malpractice RVUs associated with a given HCPCS. These RVUs are the
average RVU during the 1993 to 2002 time period.
          6
            On average, self-reported income in our sample is on par with administrative data: The Social Security Administration reports that the
median income for individuals 65 and older was $26,600 in 2010.

                                                                            11
3.2. The Medicare payment structure and relevant policy shocks

            For each HCPCS, CMS calculates a payment based on three factors: (1) the RVU, (2) a
geographic adjustment factor (GAF), and (3) a conversion factor (CF). 7 While RVUs are
procedure-specific, GAFs are region-specific, so they account for geographic variation in the cost
of providing services. 8 The CF is a nationally uniform adjustment factor that converts RVUs into
a dollar amount. This factor is updated annually by CMS according to a formula specified by
statute, but Congress can and has overridden the statutorily defined formula. 9
            To measure price elasticities, we need to identify payment changes within a market that are
independent of patient demand, technological change, and supply. If we rely on changes to the
overall Medicare payment rate, we will capture variation from RVUs, GAFs, and the CFs. Because
GAFs are set across several different markets and the CF is one number set nationally, these two
components of Medicare pricing are likely exogenous to dynamics that a given physician faces.
However, variation in RVUs may not be exogenous within a market over time. At least once every
five years, about 138 physicians from the Specialty Society Relative Value Scale Update
Committee (RUC) and its advisory committee convene to re-evaluate the work component of
RVUs, which reflects procedure-specific differences in physician time, skill, and training. If
adjustments in work RVUs are systematically correlated with demand, then price elasticity
estimates based on work RVU variation may be biased.
            We address the potential endogeneity by relying on two policy shocks in Medicare pricing.
The first major policy shock occurred in 1997 when the Healthcare Financing Administration
(HCFA) consolidated the number of geographic payment regionsâ€”known as Medicare Payment
Localities (MPLs) from 210 distinct MPLs to only 89 distinct MPLs in 1997. Discussed in
Clemens and Gottlieb (2014), this consolidation generated differential price shocks across county
groupings within a state. While some states were unaffected by this policy, in about 26 states, the
variation in reimbursement rates across counties was either significantly reduced or eliminated
because multiple regions were collapsed into one single payment area.



            7
              The exact formula for calculating Medicare payments is given by: ğ‘ƒğ‘ƒğ‘ƒğ‘ƒğ‘ƒğ‘ƒ = [ğ‘…ğ‘…ğ‘…ğ‘…ğ‘…ğ‘…ğ‘Šğ‘Š ğºğºğºğºğºğºğºğºğ‘Šğ‘Š + ğ‘…ğ‘…ğ‘…ğ‘…ğ‘…ğ‘…ğ‘ƒğ‘ƒğ‘ƒğ‘ƒ ğºğºğºğºğºğºğ¼ğ¼ğ‘ƒğ‘ƒğ‘ƒğ‘ƒ + ğ‘…ğ‘…ğ‘…ğ‘…ğ‘ˆğ‘ˆğ‘€ğ‘€ğ‘€ğ‘€ ğºğºğºğºğºğºğ¼ğ¼ğ‘€ğ‘€ğ‘€ğ‘€ ] Ã—
ğ¶ğ¶ğ¶ğ¶, where W indexes the work component, PE indexes the practice expense component, and MP indexes the malpractice expense component.
GPCI represents the geographic practice cost indices, and CF is the conversion factor.
            8
              GAF is a weighted sum of the work, practice expense, and malpractice GPCIs. Details can be found in MaCurdy et al. (2012).(MaCurdy
et al. 2012)
            9
              The CF in 2013 was $36.61 per RVU. Congress overrode this formula in 1998, 2009, and 2011.

                                                                                      12
          In contrast to the 1997 shock that differentially affected geographies (and hence all services
for a given physician uniformly), a second major policy shock in 1999 created differential changes
across services. Prior to 1999, the practice expense RVU components (PE-RVUs) were measured
using prevailing charges. However, Section 121 of the Social Security Amendments of 1994 and
the Balanced Budget Act of 1997 mandated two changes to PE-RVUs to be phased in over a four-
year period from 1999 to 2002. First, PE-RVUs were to be determined by relative costs, instead
of prevailing charges. Second, PE-RVUs were modified to better account for cost differences of
performing a procedure in a â€œfacilityâ€â€”such as a hospital, skilled nursing facility, or ambulatory
surgical centerâ€”versus a â€œnon-facility,â€ such as an office or clinic. 10

                                                      [Insert Figure 4 Here]

          Using data from Federal Register reports, we depict in Figure 4 the variation in the GAF
and PE-RVU components of Medicare reimbursements over time. Plot (a) shows the change in
GAF among counties that were affected by the 1997 consolidation versus those that were
unaffected. Much of the pre-1997 differentiation across counties was eliminated post-1997. Plot
(b) illustrates the change in average facility and non-facility PE-RVUs across HCPCS over time.
While the transition from charge- to resource-based estimations was phased in over a four-year
period, the differentiation between facility and non-facility RVUs occurred immediately and
created a sudden drop in average PE-RVUs. As Appendix Figure B1 depicts, much of the observed
drop in PE-RVUs in 1999 comes from changes in the non-facility estimates. Changes in the other
components of Medicare reimbursements are also discussed in Appendix B.

3.3. Empirical Approach

3.3.1. Identifying Exogenous Price Variation
As discussed in Section 3.2, there are several reasons why Medicare reimbursement changes may
not be exogenous. Given the political nature of RVU changes, more popular procedures may
draw higher Medicare payment increases. Alternatively, changes in payments may reflect recent
or contemporaneous changes in the cost of performing a given procedure. 11 If costs are serially

            10
               Prior to 1999, the non-facility PE-RVU was simply 50% if the facility PE-RVU (Maxwell and Zuckerman 2007). We provide
additional details regarding this policy change in Appendix B.
            11
               Although CMS uses the decennial census to determine certain indices, such as employee wage indices, it also uses the most recent
retrospective data to determine other indices, such as office rental expenses.

                                                                           13
correlated, then changes in overall payment may be correlated with changes in costs. Finally,
CMS updates RVUs based on comments submitted by physicians, health care workers, and
professional associations and societies, increasing the likelihood of payment changes being
correlated with other local supply factors (Federal Register 1999).
       In light of the potential threats to exogeneity, we use the 1997 geographic-specific shock
and the 1999 PE-RVU procedure-specific shock for identification. These two shocks generated
exogenous variation in Medicare reimbursements that is arguably unrelated to the local demand
for and supply of services. We use them as instruments for observed Medicare payments. Our first
stage identifies the predictability of PE-RVU and GAF changes on overall Medicare payment
changes while controlling for other covariates.
       To isolate changes in GAF that are due to the 1997 policy change, our GAF instrument is
calculated as the change in GAF from 1996 to 1997 that a given physician experiences.
Specifically, in years prior to 1997, the instrument is equal to zero, and from 1997 onward, the
instrument equals the one-time 1996 to 1997 change in GAF.
       Our second instrument isolates changes due to the 1999 PE-policy change. The PE-RVU
instrument equals zero prior to 1999. From 1999 to 2002 when the new cost-based methodology
was phased in, the instrument equals the annual change in each physicianâ€™s PE-RVU index. Note
that the 1999 policy shock differentially affected payments for procedures performed in a facility
(e.g., hospital, ambulatory surgical center, skilled nursing facility) versus a non-facility setting
(e.g., office, clinic). Physicians may have responded by altering their mix of facility versus non-
facility procedures. To eliminate these physician responses from our instrument, we hold constant
the share of a given service performed in the facility setting at the pre-policy years. Specifically,
for physician ğ‘–ğ‘– performing HCPCS â„ in year ğ‘¡ğ‘¡, we calculate:
                        ï¿½ ğ‘–ğ‘–â„ğ‘¡ğ‘¡ = ğ‘ ğ‘ ï¿½ï¿½ï¿½ï¿½               ğ‘“ğ‘“                          ğ‘›ğ‘›ğ‘›ğ‘›
                      ğ‘ƒğ‘ƒğ‘ƒğ‘ƒğ‘ƒğ‘ƒğ‘ƒğ‘ƒğ‘ƒğ‘ƒ      ğš¤ğš¤â„ âˆ— ğ‘ƒğ‘ƒğ‘ƒğ‘ƒğ‘ƒğ‘ƒğ‘ƒğ‘ƒğ‘ˆğ‘ˆğ‘¡ğ‘¡ + (1 âˆ’ ï¿½ï¿½ï¿½ï¿½)
                                                                ğ‘ ğ‘ ğš¤ğš¤â„ âˆ— ğ‘ƒğ‘ƒğ‘ƒğ‘ƒğ‘ƒğ‘ƒğ‘ƒğ‘ƒğ‘ˆğ‘ˆğ‘¡ğ‘¡ ,             (5)

where the ğ‘“ğ‘“ and ğ‘›ğ‘›ğ‘›ğ‘› superscripts denote facility and non-facility components, respectively, and ï¿½ï¿½ï¿½ï¿½
                                                                                                  ğ‘ ğ‘ ğš¤ğš¤â„
denotes the average share of services from 1996 to 1998 that were performed in a facility setting
                                                               ï¿½ ğ‘–ğ‘–ğ‘–ğ‘–ğ‘–ğ‘– ), which is a weighted
for a given physician-HCPCS. Next, we create a PE-RVU index (ğ‘ƒğ‘ƒğ‘ƒğ‘ƒğ‘ƒğ‘ƒğ‘ƒğ‘ƒğ‘ƒğ‘ƒ
sum of each physicianâ€™s BETOS-specific basket of procedures (ğ‘ ğ‘ ). The weights, which are
constant over time, are the same as those used in constructing the physician price index described
                                                             ï¿½ ğ‘–ğ‘–ğ‘–ğ‘–ğ‘–ğ‘– for the policy transition years
in Section 3.1. Finally, we calculate the annual change in ğ‘ƒğ‘ƒğ‘ƒğ‘ƒğ‘ƒğ‘ƒğ‘ƒğ‘ƒğ‘ƒğ‘ƒ
1999 to 2002.

                                                         14
           The two instruments defined above result in the following first-stage equation:
                                                                           ï¿½ ğš¤ğš¤ğš¤ğš¤ğš¤ğš¤ + Î“ğ‘‹ğ‘‹ğ‘—ğ‘—ğ‘—ğ‘— + ğœ‰ğœ‰ğ‘ ğ‘  + ğœ‚ğœ‚ğ‘¡ğ‘¡ + ğœˆğœˆğ‘–ğ‘–ğ‘–ğ‘–ğ‘–ğ‘– .
                     ğ¿ğ¿ğ¿ğ¿ğ¿ğ¿(ğ‘ƒğ‘ƒğ‘–ğ‘–ğ‘–ğ‘–ğ‘–ğ‘– ) = ğœ†ğœ† + ğœ“ğœ“1 ğ›¥ğ›¥ğ›¥ğ›¥ğ›¥ğ›¥ğ¹ğ¹ğ‘–ğ‘–ğ‘–ğ‘– + ğœ“ğœ“2 ğ›¥ğ›¥ğ‘ƒğ‘ƒğ‘ƒğ‘ƒğ‘ƒğ‘ƒğ‘ƒğ‘ƒğ‘ˆğ‘ˆ                                                                (6)

           ğ‘ƒğ‘ƒğ‘–ğ‘–ğ‘–ğ‘–ğ‘–ğ‘– is the physicianâ€™s BETOS-specific price index as described in Section 3.1. We
additionally control for BETOS-category fixed effects (ğœ‰ğœ‰ğ‘ ğ‘  ); year fixed effects (ğœ‚ğœ‚ğ‘¡ğ‘¡ ), and a set of
patient characteristics (ğ‘‹ğ‘‹ğ‘—ğ‘—ğ‘—ğ‘— ), including age and indicators for male, White, Black, Hispanic, and
married. ğœˆğœˆğ‘–ğ‘–ğ‘–ğ‘–ğ‘–ğ‘– is an idiosyncratic error term. Appendix Figure B2 plots the price variation we capture
from each of these instruments. Plot (a) shows the change in the geographic GAF consolidation
from 1996 to 1997, whereas plot (b) shows the annual change in the PE-RVU physician baskets
from 1998 to 2002. 12


3.3.2. Identifying the Impact of Patient Socioeconomic Status on Physician Price Responses
           With our first stage estimates in hand, we can identify how a given physician changes her
behavior in response to patient socioeconomic status. To identify this effect, our second-stage
equation is an interacted fixed-effects model of the following form:
logï¿½ğ‘…ğ‘…ğ‘…ğ‘…ğ‘ˆğ‘ˆğ‘–ğ‘–ğ‘–ğ‘–ğ‘–ğ‘–ğ‘–ğ‘– ï¿½ = ğœ†ğœ†ğ¹ğ¹ğ¹ğ¹ + ğ›½ğ›½1ğ¹ğ¹ğ¹ğ¹ log(ğ‘ƒğ‘ƒğ‘–ğ‘–ğ‘–ğ‘–ğ‘–ğ‘– ) + ğ›½ğ›½2ğ¹ğ¹ğ¹ğ¹ ï¿½log(ğ‘ƒğ‘ƒğ‘–ğ‘–ğ‘–ğ‘–ğ‘–ğ‘– ) âˆ— ğ‘ğ‘ğ‘—ğ‘—ğ‘—ğ‘— ï¿½ + ğ›½ğ›½3ğ¹ğ¹ğ¹ğ¹ ğ‘ğ‘ğ‘—ğ‘—ğ‘—ğ‘— + ğ›¤ğ›¤ ğ¹ğ¹ğ¹ğ¹ ğ‘‹ğ‘‹ğ‘—ğ‘—ğ‘—ğ‘— + ğœ‰ğœ‰ğ‘ ğ‘ ğ¹ğ¹ğ¹ğ¹ + ğœ‚ğœ‚ğ‘¡ğ‘¡ğ¹ğ¹ğ¹ğ¹ +
ğœ™ğœ™ğ‘–ğ‘–ğ¹ğ¹ğ¹ğ¹ + ğœ–ğœ–ğ‘–ğ‘–ğ‘–ğ‘–ğ‘–ğ‘–ğ‘–ğ‘–
             ğ¹ğ¹ğ¹ğ¹
                      .                                             (7)

           ğ‘…ğ‘…ğ‘…ğ‘…ğ‘ˆğ‘ˆğ‘–ğ‘–ğ‘–ğ‘–ğ‘–ğ‘–ğ‘–ğ‘– measures the total RVUs that patient ğ‘—ğ‘— received from physician ğ‘–ğ‘– in year ğ‘¡ğ‘¡ for
BETOS services s. ğ‘ğ‘ğ‘—ğ‘—ğ‘—ğ‘— represents measures of patient socioeconomic status, including log patient
income or patient education. In addition to patient covariates, year fixed effects, and BETOS-
category fixed effects, we control for physician fixed effects (ğœ™ğœ™ğ‘–ğ‘–ğ¹ğ¹ğ¹ğ¹ ). When estimating this model,
we add the physician fixed-effects to the first-stage Equation (6) as well. We cluster standard errors
at the 210 pre-1997 MPLs (i.e., the geographic payment regions), and we scale the sample weights
so that each physician possesses equal weight.
           Because of the interaction terms, we require additional first-stage equations. The interacted
                                                                                  ï¿½ ğš¤ğš¤ğš¤ğš¤ğš¤ğš¤ Ã— ğ‘ğ‘ğ‘—ğ‘—ğ‘—ğ‘— . Following Aiken
variable log(ğ‘ƒğ‘ƒğ‘–ğ‘–ğ‘–ğ‘–ğ‘–ğ‘– ) Ã— ğ‘ğ‘ğ‘—ğ‘—ğ‘—ğ‘— is instrumented by Î”ğºğºğºğºğ¹ğ¹ğ‘–ğ‘–ğ‘–ğ‘– Ã— ğ‘ğ‘ğ‘—ğ‘—ğ‘—ğ‘— and Î”ğ‘ƒğ‘ƒğ‘ƒğ‘ƒğ‘ƒğ‘ƒğ‘ƒğ‘ƒğ‘ˆğ‘ˆ
and West (1991), we demean the price and socioeconomic status variables, log(ğ‘ƒğ‘ƒğ‘–ğ‘–ğ‘–ğ‘–ğ‘–ğ‘– ) and ğ‘ğ‘ğ‘—ğ‘—ğ‘—ğ‘— , so
that ğ›½ğ›½2ğ¹ğ¹ğ¹ğ¹ represents the relationship between patient socioeconomic status and physician supply




           12
            To further illustrate the how the PE-RVU instrument changes across services, we plot in Appendix Figure B3 the distribution of PE-
RVU changes from 1998 to 2002 by service. While the PE-RVU decreased for some HCPCS, it increased significantly for other services.

                                                                               15
responses at the average price and average patient socioeconomic status. If ğ›½ğ›½2ğ¹ğ¹ğ¹ğ¹ > 0, then
physician supply responses are stronger (i.e., more positive) among richer patients.


3.3.3. Mitigating Bias and Assessing Validity
          While our instruments ensure that we examine exogenous changes in price, we lack
instruments for socioeconomic status. This leads to a few sources of potential bias. First, there may
be sorting between patients and physicians such that some patients seek out more altruistic
physicians. To mitigate this bias, we present within-physician estimates using the regression model
in Equation (7). Second, the length of the physician-patient relationship may affect the physicianâ€™s
degree of altruism across patients. Although the panels of the MCBS data are too short to
accurately track physician-patient relationship lengths, the existing literature suggests that poorer
patients are more likely to have shorter-tenured relationships with their physicians (Fairbrother et
al. 2004; Donahue, Ashkin, and Pathman 2005; Sommers and Rosenbaum 2011). As such, this
mechanism is likely to make physicians more altruistic towards richer patients, biasing downward
the estimated differences across patient socioeconomic status measured by ğ›½ğ›½2ğ¹ğ¹ğ¹ğ¹ in the fixed-effects
regression Equation (7). Thus, our estimates may understate the extent to which socioeconomic
status affects physician supply responses.
          There is well-documented variation in health status across socioeconomic groups. Thus,
we are also concerned that our estimated effects of â€œsocioeconomic statusâ€ are simply effects of
variation in baseline health. As a test for this bias, we assess how the coefficients change as we
include a varying number of observable controls for patient health characteristics (Altonji, Elder,
and Taber 2005; Oster 2016). 13 Detailed in Appendix B, we construct measures from claims and
survey data, including the Charlson Comorbidity Index (CCI), body mass index, and eight
indicators for having a broken hip, cancer, diabetes, heart disease, hypertension, lung disease,
neurological disease, or self-reported difficulty with physical functioning (Quan et al. 2005). The
summary statistics for these variables are shown in Table 1. While the higher income patients have
a higher CCI and marginally higher rates of cancer, they have lower rates of disease incidence as
measured by the other eight health metrics.




          13
               Because ğ‘…ğ‘… 2 values have little statistical meaning in the 2SLS setting, we cannot bound our estimates precisely as prescribed by Oster
(2016).

                                                                              16
          Next, in the absence of an experiment in socioeconomic status, we cannot definitively rule
out selection bias from the sorting of physicians and patients. Fortunately, much of the empirical
literature suggests that the average patient may not actively or aggressively seek out physicians
with particular characteristics: only a minority of patients actively search for a physician, and since
many patients may have access to only one provider offering a given service, shopping for services
across providers is estimated to occur in around 7% of health care spending (Harris, 2003; Frost
and Newman 2016). If richer patients seek out physicians who provide more services, our
estimated variation in the price elasticity will be conservative.
          Finally, to ensure that our estimates represent a direct policy response, we also estimate the
full parametric event study. Modifying the second-stage fixed-effects regression Equation (7), we
interact the key variables of interestâ€” log(ğ‘ƒğ‘ƒğ‘–ğ‘–ğ‘–ğ‘–ğ‘–ğ‘– ) and ï¿½log(ğ‘ƒğ‘ƒğ‘–ğ‘–ğ‘–ğ‘–ğ‘–ğ‘– ) Ã— ğ‘ğ‘ğ‘—ğ‘—ğ‘—ğ‘— ï¿½ â€” with single-year dummies.
                                           ï¿½ ğš¤ğš¤ğš¤ğš¤ğš¤ğš¤ , Î”ğºğºğºğºğ¹ğ¹ğ‘–ğ‘–ğ‘–ğ‘– Ã— ğ‘ğ‘ğ‘¡ğ‘¡ğ‘¡ğ‘¡ , Î”ğ‘ƒğ‘ƒğ‘ƒğ‘ƒğ‘ƒğ‘ƒğ‘ƒğ‘ƒğ‘ˆğ‘ˆ
We then instrument with Î”ğºğºğºğºğ¹ğ¹ğ‘–ğ‘–ğ‘–ğ‘– , Î”ğ‘ƒğ‘ƒğ‘ƒğ‘ƒğ‘ƒğ‘ƒğ‘ƒğ‘ƒğ‘ˆğ‘ˆ                                 ï¿½ ğš¤ğš¤ğš¤ğš¤ğš¤ğš¤ Ã— ğ‘ğ‘ğ‘¡ğ‘¡ğ‘¡ğ‘¡ , each of which is

also interacted with single-year dummies as well. In this event study specification, we omit the
dummy for 1996 so that physician responses are estimated relative to a pre-policy shock year. For
ease of inspection, we present the event study evidence graphically, plotting responses for patients
at the mean income or education. 14


Highlighting Variation in Physician Supply Responses
          While the prior analyses specifically address how a given physician changes her behavior
in response to patient characteristics, they mask the heterogeneity of responses across physicians.
To characterize the distribution of physician supply responses within patient socioeconomic status
groups, we estimate an alternative second-stage equation, using a random coefficients model of
the following form:
         logï¿½ğ‘…ğ‘…ğ‘…ğ‘…ğ‘ˆğ‘ˆğ‘–ğ‘–ğ‘–ğ‘–ğ‘–ğ‘–ğ‘–ğ‘– ï¿½ = (ğœ†ğœ†ğ‘…ğ‘…ğ‘…ğ‘… + ğ‘™ğ‘™ğ‘–ğ‘–ğ‘…ğ‘…ğ‘…ğ‘… ) + ï¿½ğ›½ğ›½ ğ‘…ğ‘…ğ‘…ğ‘… + ğ‘ğ‘ğ‘–ğ‘–ğ‘…ğ‘…ğ‘…ğ‘… ï¿½ log(ğ‘ƒğ‘ƒğ‘–ğ‘–ğ‘–ğ‘–ğ‘–ğ‘– ) + ğ›¤ğ›¤ ğ‘…ğ‘…ğ‘…ğ‘… ğ‘‹ğ‘‹ğ‘—ğ‘—ğ‘—ğ‘— + ğœ‰ğœ‰ğ‘ ğ‘ ğ‘…ğ‘…ğ‘…ğ‘… + ğœ‚ğœ‚ğ‘¡ğ‘¡ğ‘…ğ‘…ğ‘…ğ‘… + ğœ–ğœ–ğ‘–ğ‘–ğ‘–ğ‘–ğ‘–ğ‘–ğ‘–ğ‘–
                                                                                                                                       ğ‘…ğ‘…ğ‘…ğ‘…
                                                                                                                                                  (8)

          As noted above, we control for patient characteristics, BETOS-category fixed effects, and
                      ğ‘…ğ‘…ğ‘…ğ‘…
year fixed effects. ğœ–ğœ–ğ‘–ğ‘–ğ‘–ğ‘–ğ‘–ğ‘–ğ‘–ğ‘– is an idiosyncratic error term. This approach allows each physician to have
a random slope (ğ‘ğ‘ğ‘–ğ‘–ğ‘…ğ‘…ğ‘…ğ‘… ) and intercept (ğ‘™ğ‘™ğ‘–ğ‘–ğ‘…ğ‘…ğ‘…ğ‘… ), and it shrinks physician-specific elasticities towards the
mean. We estimate the random-coefficients Equation (8) for three terciles of patient income and



            14
               Following Clemens and Gottlieb (2014), the change in GAF and PE-RVU instruments are constant over the pre-treatment time period
so that pre-trends can be estimated.

                                                                                17
three terciles of patient education, and we again scale the sample weights so that each physician
possesses equal weight.

4. Results

4.1. Within-Physician Changes in Supply Response

                                                        [Insert Table 2 Here]

       We begin by conducting the interacted fixed-effects estimation. Table 2 presents the
results. In Panel A, we estimate the effects without any controls for patient health; Panel B repeats
the same analysis with the full set of controls for patient health (described in Section 3.3).
Comparing the two specifications helps us assess whether variation in patient health across
socioeconomic status groups contaminates the estimated effects of interest.
       The table shows that, on average, price responses are positive. This is consistent with the
                                                                                    ğœ•ğœ•ğœ•ğœ•
â€œphysician-drivenâ€ supply response assumption of                                    ğœ•ğœ•ğœ•ğœ•
                                                                                           > 0 in Proposition 1 and with prior

empirical literature (Clemens and Gottlieb, 2014). Moreover, the negative coefficient on income
                                                                                  ğœ•ğœ•ğœ•ğœ•
suggests we are in the case of private under-use where                             ğœ•ğœ•ğœ•ğœ•
                                                                                          < 0 (Figure 3, Panel b). Since all patients

in our sample have Medicare coverage (with some having additional coverage), it is perhaps not
surprising that we find marginal out-of-pocket costs to be lower than marginal benefits. 15 In any
event, the main effect sizes of income on utilization are modest, with a 10% increase in income
reducing utilization by 0.07% and an additional year of education reducing utilization by 0.01%.
       In columns (2) to (4), we examine the interaction effects between patient socioeconomic
status and physician responses. All interaction effects are positive, indicating that physicians
respond more positively to price increases for patients with higher socioeconomic status. A 10%
increase in patient income is associated with an increase of 0.05 in the price elasticity, or a 50%
increase from the mean elasticity of 0.095. An additional year of education is correlated with a
0.014 unit increase in price elasticity, an 11% increase from the mean elasticity of 0.122.
       Finally, comparing the top and bottom panels of the table reveals that the estimated
interaction terms do not change appreciably, if at all, when controlling for additional underlying



       15
            It is worth reiterating that private under-use is not inconsistent with social over-use.

                                                                              18
characteristics of patient health. The education interaction terms are unchanged by the introduction
of observable health controls. The income interaction increases modestlyâ€”by about 1.14%
(equivalent to 3.5% of the associated standard error). This provides some comfort and suggests
that the estimated interactions may not simply be proxies for the relationship between patient
health and physician supply responses.
          Table 2 also presents some regression diagnostics. The first stage F-statistics, the Hansen
J-statistic, and the C-statistic test for endogeneity are all reported under each set of regression
results. The F-statistic ranges from 21 to 62, well exceeding the â€œrule of thumbâ€ cut-off of 10 (Olea
and Pflueger 2013; Staiger and Stock 1997; Stock and Yogo 2005). We test whether we should
use one instrument or two by performing the Sargan-Hansen test, which reveals that the
overidentifying restrictions are not rejected: the J-Statistic consistently has p-values above 0.05
and above 0.1 in most specifications. Therefore, we rely on both instruments. Finally, to evaluate
the need for instrumental variables, we calculate the C-statistic under the null that exogeneity is
supported by the data and both OLS and 2SLS are consistent estimators. This statistic is calculated
by examining the difference of two Sargan-Hansen statistics: one where payments are treated as
endogenous (i.e., 2SLS) and another where payments are treated as exogenous (i.e., OLS). 16 The
data reject OLS in favor of 2SLS at the 5% level of significance.

4.2. Assessing Validity

          The coefficients from the parametric event study appear in Figure 5.

                                                     [Insert Figure 5 Here]

The graph represents changes in physician price responses, relative to the pre-policy year 1996,
and the responses are estimated for a patient with mean income and education. The pre-trends are
not statistically different from zero, consistent with a lack of correlation between our price shocks
and quantity changes in the pre-reform period. Following 1997 (the GAF change), physician
supply responses appear and persist through 2002.




16
   Under homoscedasticity, this test is numerically equivalent to a Hausman test (Hayashi 2000). The C-statistic, unlike the Durbin-Wu-Hausman
test, is robust to violations of homoskedasticity (Hansen 1982; Sargan 1958) .

                                                                          19
4.3. Heterogeneity in Physician Price Responses

           We next illustrate the heterogeneity in physician price responses by estimating the random
coefficients model specified in Equations (6) and (8).

                                                       [Insert Figure 6 Here]

                                                                      ğ‘…ğ‘…ğ‘…ğ‘… + ğ‘ğ‘ï¿½
Figure 6 plots the distribution of physician-specific elasticities (ğ›½ğ›½ï¿½        ğ‘…ğ‘…ğ‘…ğ‘…
                                                                               ğš¤ğš¤ ), by three levels of

patient income (plot a) or education (plot b). The plots highlight a rightward shift in the physician
elasticity distribution as patient income and education rise. In other words, physician supply
responses are stronger and more positive among higher terciles of patient income and education.
More importantly, the figure also highlights the heterogeneity in pricing dynamics across
physicians, a fact that can be easily masked when estimating average price elasticities. 17

4.4 Implications for Medicare Reimbursement Reform

           We explore the broader implications of our findings by examining the within-physician
variability of price elasticities and the extent to which reimbursement reforms differentially affect
patients in different socioeconomic strata.

                                                       [Insert Figure 7 Here]

           In Figure 7, we calculate within-physician elasticities across the patient distribution for the
average physician. This equates to calculating ( ğ›½ğ›½ï¿½
                                                   ğ¹ğ¹ğ¹ğ¹ ï¿½ğ¹ğ¹ğ¹ğ¹
                                                   1 + ğ›½ğ›½2 Zjt) from the fixed-effects regression

Equation (7) at different points of the patient socioeconomic status distribution. We consider the
median and interdecile ranges (10th, 50th, and 90th percentiles) and test whether the average
physicianâ€™s price response differs across these ranges using a block bootstrap approach that takes
1,000 draws, resampling at the physician level. Figure 7 shows that within the average physician,
the price elasticity ranges from 0.02 to 0.18 as a result of variation in patient socioeconomic status.
The bootstrap errors indicate that the within-physician elasticity estimates at the 10th and 50th



           17
              We focus on the distributional implications of the random-coefficients model rather than the estimated mean supply response, because
random-coefficients models are known to suffer from poor matches to in-sample means (Klaiber and von Haefen 2018). We rely on the fixed-
effects model, which yields estimates that match the data means exactly, as our main specification.

                                                                            20
percentiles of patient income and education are statistically different, as well as the within-
physician elasticity estimates at the 50th and 90th percentiles of patient income and education.

                                                     [Insert Figure 8 Here]

          In general, these numbers suggest that Medicare reimbursement reforms will have unequal
effects across socioeconomic groups. Figure 8 illustrates what the elasticity differences in Figure
7 mean for the effects of the two reforms studied. The red and blue curves reflect the actual
percentage growth in utilization for high- and low-income patients. 18 They are computed
identically to the curves in Figure 1, but reported in percentage growth terms for consistency with
our estimates. The remaining two curves report the actual (solid grey) and predicted (black dashed)
excess utilization growth for high-income patients. The red and blue curves imply that high-
income patients experienced an increase in RVUs of 104% over this entire period, compared to
82% for the low-income counterparts. This translates into 22.2 percentage points more actual
growth for the high-income patients, as depicted in the solid grey curve. Finally, the black dashed
line illustrates that our estimated differences in physician supply responses explain 10.4 percentage
points of this excess growth, or about 53%.
          According to the solid grey curve, actual utilization trends seem to take one or two years
to respond to the Medicare policy shock. While the precise dynamics of how and when physicians
respond to reimbursement changes remains beyond the scope of this paper, we note this general
pattern is consistent with prior literature on the effects of Medicare reimbursement reforms
(Clemens and Gottlieb 2014). 19

5. Conclusion

          In this paper, we present a model of decision-making by physicians with imperfect altruism
towards their patients. We show that the same physician may respond differently to price changes
when treating patients with different socioeconomic status. We compute the size and direction of
this effect empirically: within-physician price elasticities vary from 0.02 to 0.18 across the 10th
and 90th percentiles of the patient socioeconomic status distribution. On average, the Medicare


          18
                 High- and low-income patients are defined as those with above- and below-median income levels. We follow the trend in total
utilization for the median patient.
             19
                In Clemens and Gottlieb (2014), responses to the GAF policy response peaks in 1999.

                                                                         21
policy shocks studied increase utilization by 10.4 percentage points more for higher income
patients.
        While our measures of price elasticities rely on plausibly exogenous variation, future
research could study not only exogenous changes in reimbursement, but also natural experiments
in patient socioeconomic status across physicians. In addition, we have taken as given that
physicians choose treatments on behalf of their patients. In some cases, patients may have more
influence over the outcome; such shared decisionâ€“making can be influenced by the length of the
physician-patient relationship. The implications of the physician-patient relationship for price
elasticity represent another fertile area for future research using longer-term data.
        The health economics literature has long recognized the tension between physician altruism
and physician profit-maximization, and in prior research, economists have developed elegant and
tractable models accounting for this tension. We exploit these tools to investigate how patient
socioeconomic status impacts pricing and utilization behavior in healthcare markets. Our analysis
demonstrates that the unique preferences and objectives of physicians create price responses that
vary across socioeconomic groups. Our empirical results provide guidance for policymakers and
researchers. Heterogeneity in the effect of reimbursement changes is to be expected, and
policymakers ought to account for the unequal effects of pricing reforms on patients in different
socioeconomic strata. Suitably directed empirical analysis can help inform more targeted
approaches to reforming reimbursement policy, particularly when the goal is to protect vulnerable
socioeconomic groups.


Acknowledgments

We gratefully acknowledge comments from Joshua Gottlieb and other participants at the American
Economic Association Annual Meeting, the BU-Harvard-MIT Health Seminar, the NBER Health
Care Summer Institute, the Midwest Health Economics Seminar, and the USC CESR-Schaeffer
Brown Bag. Research reported here was supported by the National Institute on Aging of the
National    Institutes   of   Health   under   award    number    P01AG033559,          P30AG024968,
2P30AG043073-06, 1R01AG062277, and 3R01AG055401-02S2. The content is solely the
responsibility of the authors and does not necessarily represent the official views of the National
Institutes of Health. Lakdawalla discloses that he is a consultant to Precision Health Economics


                                                       22
(PHE), and a shareholder in its parent company, Precision Medicine Group. PHE provides research
and consulting services to firms in the life sciences and health insurance industries.



REFERENCES

Aiken, Leona S, and Stephen G West. 1991. Multiple Regression Testing and Interpreting
        Interactions (Sage Publications: Thousand Oaks, CA).
Altonji, Joseph G, Todd E Elder, and Christopher R Taber. 2005. 'Selection on Observed and
        Unobserved Variables: Assessing the Effectiveness of Catholic Schools', Journal of
        Political Economy, 113: 151-84.
Arrow, Kenneth J. 1963. 'Uncertainty and the Welfare Economics of Medical Care', American
        Economic Review, 53: 941-73.
Becker, Gary. 1957. The Economics of Discrimination (The University of Chicago Press: Chicago,
        IL).
Becker, Gary S, and Kevin M Murphy. 1988. 'A Theory of Rational Addiction', Journal of Political
        Economy, 96: 675-700.
Blomqvist, Ake. 2002. 'Defining the Value of a Statistical Life: A Comment', J Health Econ, 21:
        169-75.
Chew, S. H., L. G. Epstein, and U. Segal. 1991. 'Mixture Symmetry and Quadratic Utility',
        Econometrica, 59: 139-63.
Chone, Philippe, and Ching-to Albert Ma. 2011. 'Optimal Health Care Contract under Physician
        Agency', Annals of Economics and Statistics: 229-56.
Clemens, Jeffrey, and Joshua D. Gottlieb. 2014. 'Do Physicians' Financial Incentives Affect
        Medical Treatment and Patient Health?()', The American Economic Review, 104: 1320-49.
Dickstein, Michael. 2016. 'Patient vs. Patient Incentives in Prescription Drug Choice', Working
        Paper.
Donahue, Katrina E., Evan Ashkin, and Donald E. Pathman. 2005. 'Length of patient-physician
        relationship and patients' satisfaction and preventive service use in the rural south: a cross-
        sectional telephone study', BMC Family Practice, 6: 40-40.
Dranove, D., and W. D. White. 1987. 'Agency and the organization of health care delivery',
        Inquiry, 24: 405-15.
Dranove, David. 1988. 'Demand Inducement and the Physician/Patient Relationship', Economic
        Inquiry, 26: 281-98.
Ellis, R. P., and T. G. McGuire. 1990. 'Optimal payment systems for health services'.
Ellis, Randall P., and Thomas G. McGuire. 1986. 'Provider behavior under prospective
        reimbursement: Cost sharing and supply', J Health Econ, 5: 129-51.
Emanuel, E. J., and L. L. Emanuel. 1992. 'Four models of the physician-patient relationship',
        JAMA, 267: 2221-26.
Evans, William N., and W. Kip Viscusi. 1993. 'Income Effects and the Value of Health', The
        Journal of Human Resources, 28: 497-518.
Fairbrother, Gerry, Aparna Jain, Heidi L Park, Mehran S Massoudi, Arfana Haidery, and Bradford
        H. Gray. 2004. 'Churning in Medicaid Managed Care and Its Effect on Accountability',
        Journal of Health Care for the Poor and Underserved, 15: 30-41.


                                                      23
Federal Register. 1999. "Medicare Program; Payment Policies Under Physician Fee Schedule for
        Calendar Year 2000." In 42 CFR Parts 410, 411, 414, 415, and 485, edited by Department
        of Health and Human Services.
Finkelstein, Amy, Erzo F. P. Luttmer, and Matthew J. Notowidigdo. 2013. 'What Good is Wealth
        Without Health? The Effect of Health on the Marginal Utility of Consumption', Journal of
        the European Economic Association, 11: 221-58.
Glied, Sherry, and Joshua Graff Zivin. 2002. 'How do doctors behave when some (but not all) of
        their patients are in managed care?', J Health Econ, 21: 337-53.
Godager, Geir, and Daniel Wiesen. 2013. 'Profit or patientsâ€™ health benefit? Exploring the
        heterogeneity in physician altruism', J Health Econ, 32: 1105-16.
Gruber, Jonathan (ed.)^(eds.). 2013. Proposal 3: Restructuring Cost Sharing and Supplemental
        Insurance for Medicare (Brookings).
Hansen, Lars Peter. 1982. 'Large Sample Properties of Generalized Method of Moments
        Estimators', Econometrica, 50: 1029-54.
Hayashi, Fumio. 2000. Econometrics (Princeton University Press: Princeton, NJ).
Jack, William. 2005. 'Purchasing health care services from providers with unknown altruism', J
        Health Econ, 24: 73-93.
Jacobson, Mireille G., Tom Y. Chang, Craig C. Earle, and Joseph P. Newhouse. 2017. 'Physician
        Agency and Patient Survival', Journal of Economic Behavior & Organization, 134: 27-47.
Klaiber, H. Allen, and Roger H. von Haefen. 2018. 'Do Random Coefficients and Alternative
        Specific Constants Improve Policy Analysis? An Empirical Investigation of Model Fit and
        Prediction', Environmental and Resource Economics: 1-17.
Lillard, Lee A., and Yoram Weiss. 1997. 'Uncertain Health and Survival: Effects on End-of-Life
        Consumption', Journal of Business & Economic Statistics, 15: 254-68.
Liu, Ting, and Ching-to Albert Ma. 2013. 'Health insurance, treatment plan, and delegation to
        altruistic physician', Journal of Economic Behavior & Organization, 85: 79-96.
MaCurdy, Thomas, Jason Shafrin, Thomas DeLeire, Jed DeVaro, Mallory Bounds, David Pham,
        and Arthur Chia. 2012. Geographic Adjustment of Medicare Payments to Physicians:
        Evaluation of IOM Recommendations (Acumen, LLC: Burlingame, CA).
Maxwell, Stephanie, and Stephen Zuckerman. 2007. 'Impact of Resource-Based Practice Expenses
        on the Medicare Physician Volume', Health Care Financing Review, 29: 65-79.
McGuire, Thomas G. 2000. 'Physician Agency.' in A. Culyer, J., Newhouse J.P. (ed.), Handbook
        of Health Economics (Elsevier Science B.V.).
McGuire, Thomas G., and Mark V. Pauly. 1991. 'Physician Response to Fee Changes with
        Multiple Payers', J Health Econ, 10: 385-410.
Mooney, G., and M. Ryan. 1993. 'Agency in health care: getting beyond first principles', J Health
        Econ, 12: 125-35.
Olea, JosÃ© Luis Montiel, and Carolin Pflueger. 2013. 'A Robust Test for Weak Instruments',
        Journal of Business & Economic Statistics, 31: 358-69.
Oster, Emily. 2016. 'Unobservable Selection and Coefficient Stability: Theory and Evidence',
        Journal of Business & Economic Statistics: 1-18.
Quan, H., V. Sundararajan, P. Halfon, A. Fong, B. Burnand, J. C. Luthi, L. D. Saunders, C. A.
        Beck, T. E. Feasby, and W. A. Ghali. 2005. 'Coding algorithms for defining comorbidities
        in ICD-9-CM and ICD-10 administrative data', Medical Care, 43: 1130-9.
Rochaix, Lise. 1989. 'Information asymmetry and search in the market for physicians' services', J
        Health Econ, 8: 53-84.

                                                  24
Sargan, J. D. 1958. 'The Instability of the Leontief Dynamic Model', Econometrica, 26: 381-92.
Sommers, Benjamin D., and Sara Rosenbaum. 2011. 'Issues In Health Reform: How Changes In
        Eligibility May Move Millions Back And Forth Between Medicaid And Insurance
        Exchanges', Health Affairs, 30: 228-36.
Staiger, Douglas O., and James H. Stock. 1997. 'Instrumental Variables Regression with Weak
        Instruments', Econometrica, 65: 557-86.
Stock, James H., and Motohiro Yogo. 2005. 'Testing for Weak Instruments in Linear IV
        Regression.' in Donald W.K. Andrews and James H. Stock (eds.), Identification and
        Inference for Econometric Models (Cambridge University Press: Cambridge, UK).
Zweifel, Peter, Friedrich Breyer, and Mathias Kifmann. 1997. Health Economics (Oxford
        University Press: New York, NY).




                                                 25
                        FIGURE 1: VARIATION IN PRICE, UTILIZATION, AND INCOME
                                  (a) Utilization by Patient Income over Time




                                        (b) Physician Price Index over Time




         Notes: Data from the Federal Register and MCBS. Plot (a) shows the median utilizationâ€”measured as Medicare Relative
Value Units (RVUs)â€” per physician-patient over time for patient income below (â€œlow incomeâ€) and above (â€œhigh incomeâ€) the
median income. Plot (b) shows the median price index for physicians. The price index is calculated as the 1993-utilization weighted
average of prices across all services that a physician performs during the time period.




                                                                    26
                     FIGURE 2: DETERMINANTS OF OPTIMAL UTILIZATION


(a) Private Over-Use: ğ’—ğ’—ğ…ğ…â€² âˆ’ ğˆğˆğ‘¿ğ‘¿ < ğŸğŸ                 (b) Private Under-Use: ğ’—ğ’—ğ…ğ… â€² âˆ’ ğˆğˆğ‘¿ğ‘¿ > ğŸğŸ


Marginal                                          Marginal
 Benefit   ğ‘£ğ‘£ğ¹ğ¹ â€²                          ğ‘ğ‘ â€²    Benefit    ğ‘£ğ‘£ğ¹ğ¹ â€²                      ğ‘ğ‘ â€²
 or Cost                                           or Cost


       P

      ÏƒX
                                                          P

                                                         ÏƒX

                    XF                Xc                                      Xc XF
                         Utilization (X)                                Utilization (X)




                                                   27
            FIGURE 3: IMPACT OF INCOME ON PHYSICIAN SUPPLY RESPONSES
(a) Private Over-Use: ğ’—ğ’—ğ…ğ…â€² âˆ’ ğˆğˆğ‘¿ğ‘¿ < ğŸğŸ      (b) Private Under-Use: ğ’—ğ’—ğ…ğ… â€² âˆ’ ğˆğˆğ‘¿ğ‘¿ > ğŸğŸ


Price (P)                                  Price (P)
                                      I0                                           I1
                                                                          B
              A                 C     I1
      P0


              B                                                                    I0
                                                 P0         C
                                                                               A




               X0               X1                          X1            X0
                    Utilization (X)                          Utilization (X)




                                           28
                        FIGURE 4: SHOCKS IN MEDICARE PAYMENT COMPONENTS
                      (a) Geographic Consolidation of Payment Regions (GAF)




                   (b) Change in Reimbursement Calculation Method (PE-RVU)




         Notes: Data from the Federal Register 1992-2003. The sample is limited to HCPS observed in all years. Plot (a) shows
the average GAF across counties that were or were not affected by the 1997 consolidation of payment regions from 210 to 89
payment regions. Plot (b) depicts the change in average PE-RVUs across HCPCS. In 1999, HCFA phased in a cost-based
methodology of calculating PE-RVUs and more accurately priced non-facility services.




                                                                 29
       FIGURE 5: IMPACT OF PRICE POLICY SHOCKS ON QUANTITY RESPONSE, BY PATIENT
                                 SOCIOECONOMIC STATUS
                                                        (a) Patient Income




                                                      (b) Patient Education




         Notes: Data from the Federal Register and MCBS. This figure shows the coefficients from a parametric event study of
Equation (9) where we interact year dummies with log price and log price multiplied by patient socioeconomic status. We omit
1996 as the reference year. The resulting coefficientsâ€”equivalent to year-specific estimates of ( ğ›½ğ›½Ì‚1ğ‘¡ğ‘¡
                                                                                                     ğ¹ğ¹ğ¹ğ¹
                                                                                                            + ğ›½ğ›½Ì‚2ğ‘¡ğ‘¡
                                                                                                                 ğ¹ğ¹ğ¹ğ¹
                                                                                                                      ğ‘ğ‘ )â€”are plotted.




                                                                      30
     FIGURE 6: PHYSICIAN-SPECIFIC RANDOM COEFFICIENTS, BY PATIENT SOCIOECONOMIC
                                       STATUS
                                                         (a) Patient Income




                                                       (b) Patient Education




          Notes: Data from the Federal Register and MCBS. We use a restricted maximum likelihood estimator to estimate
Equations (6) and (8). We stratified by patient income terciles (plot a) or patient education terciles (plot b). We plot the distribution
                             ğ‘…ğ‘…ğ‘…ğ‘… + ğ‘ğ‘ï¿½
of physician elasticities, ğ›½ğ›½ï¿½         ğ‘…ğ‘…ğ‘…ğ‘…
                                      ğš¤ğš¤ .




                                                                       31
    FIGURE 7: ELASTICITIES WITHIN PHYSICIAN, ACROSS PATIENT SOCIOECONOMIC STATUS



                                                                                                                ***
                                                                           ***

                                     ***


                                                                   ***
                                                                                                         ***
                              ***




           Notes: Data from the Federal Register and MCBS. This figure shows the within-physician quantity response to a 10%
price change. The 10th, 50th, and 90th percentile corresponds to patients with log incomes of 8.7, 9.6, 10.7 or education levels of
6.5, 12, and 19 years. The â€œAllâ€ category considers patients with both income and education in the 10th, 50th, or 90th percentile.
*** indicates that elasticity in the bar and the right of the bar (i.e., 50th and 10th percentile, or 90th and 50th percentile) are

statistically different at the 1% level.




                                                                    32
    FIGURE 8: EXPLAINED DIFFERENCES IN UTILIZATION ACROSS PATIENT INCOME GROUPS




          Notes: Data from the Federal Register and MCBS. This figure examines the difference in cumulative percent changes in
RVU for high- and low-income patients. High (low) income patients are those with income above (below) the median, and we
examine changes in the total utilization for the median patient within each income group. The red and blue lines show actual
percent changes in utilization, relative to 1996 (akin to Figure 1), and the grey line shows their difference (i.e., high â€“ low income
percent changes). The black line is the difference in percent changes in predicted utilization, as extracted from our estimate of
Equation (10).




                                                                      33
                                       TABLE 1: SUMMARY STATISTICS
                                                 Low Patient Income              High Patient Income
                                                 Mean          SD                Mean           SD
                                                  (1)          (2)                 (3)          (4)
           Key Variables
            Price Index ($)                      106.73          526.97           113.72          535.77
            Total RVUs                             5.98           17.58             5.81           16.97
            âˆ†GAF                                  0.002           0.014            0.001           0.014
            âˆ†PE-RVU                              -0.045           0.355           -0.076           0.479

           Patient Covariates
            Income ($)                          8575.47         3367.81         36987.16         55770.03
            Education (Years)                    10.00            3.35            12.75            3.31
            1(Male)                               0.33            0.47             0.50            0.50
            1(White)                              0.76            0.42             0.92            0.27
            1(Black)                              0.16            0.36             0.04            0.20
            1(Hispanic)                           0.06            0.24             0.02            0.15
            Age                                  72.88           16.03            75.54            9.69
            1(Married)                            0.24            0.43             0.67            0.47

           Health Variables
            BMI                                   26.09             6.21          25.95             5.08
            CCI                                    3.76             1.94           4.20             1.47
            1(Broken Hip)                          0.08             0.26           0.05             0.21
            1(Cancer)                              0.19             0.39           0.25             0.43
            1(Diabetes)                            0.24             0.43           0.19             0.39
            1(Heart Disease)                       0.51             0.50           0.50             0.50
            1(Hypertension)                        0.62             0.49           0.59             0.49
            1(Lung)                                0.21             0.41           0.18             0.38
            1(Neurological Disease)                0.39             0.49           0.26             0.44
            1(Physical Difficulties)               0.79             0.41           0.67             0.47

           No. Observations                             317,778                          327,912

         Notes: Data from the Federal Register and MCBS at the physician, patient, BETOS group, year level. We divide the
sample equally between low- and high-income patients.




                                                               34
                                TABLE 2: INTERACTED REGRESSION ANALYSES
                                               (1)                 (2)           (3)                             (4)
                                                             Panel A: No Health Controls
      Log(P)                               0.127***             0.103***     0.116***                        0.104***
                                           (0.0346)             (0.0358)      (0.0347)                       (0.0353)
      Log(P) x Log(Income)                                     0.0504***                                     0.0309**
                                                                (0.0139)                                     (0.0140)
      Log(P) x Education                                                    0.0140***                       0.0109***
                                                                             (0.00387)                      (0.00399)
      Log(Income)                         -0.00723**          -0.0139***    -0.00659**                     -0.0108***
                                           (0.00325)           (0.00323)     (0.00332)                      (0.00319)
      Log(Education)                       -0.000128           -1.39e-05    -0.00243**                      -0.00196*
                                          (0.000788)          (0.000786)     (0.00102)                      (0.00104)

      No Observations                       589,663              589,663               589,663               589,663
      No Physicians                          97,931               97,931                97,931                97,931
      First Stage F-Statistic                 66.39                31.55                 35.75                 22.84
      Hansen J-Statistic                      0.313                0.152                 0.342                0.0772
      Endogeneity Test                     0.000510              2.13e-05              2.17e-05              4.15e-05

                                                               Panel B: Health Controls
      Log(P)                               0.127***              0.104***      0.117***                      0.105***
                                           (0.0345)              (0.0357)      (0.0346)                      (0.0352)
      Log(P) x Log(Income)                                      0.0508***                                    0.0314**
                                                                 (0.0137)                                    (0.0139)
      Log(P) x Education                                                      0.0140***                     0.0109***
                                                                              (0.00384)                     (0.00397)
      Log(Income)                           -0.00369           -0.0105***      -0.00306                    -0.00738**
                                           (0.00315)            (0.00312)     (0.00322)                     (0.00306)
      Log(Education)                       -0.000698            -0.000547     -0.00187*                      -0.00139
                                          (0.000748)           (0.000747)     (0.00100)                     (0.00102)

      No Observations                       589,663              589,663               589,663               589,663
      No Physicians                          97,931               97,931                97,931                97,931
      First Stage F-Statistic                 62.16                29.32                 33.33                 21.07
      Hansen J-Statistic                      0.336                0.167                 0.361                0.0876
      Endogeneity Test                     0.000134              3.18e-06              4.10e-06              9.10e-06

           Notes: Data from the Federal Register and MCBS. All regressions control for patient characteristics (male, white, black,
Hispanic, age, married, log income, and years of education), physician fixed effects, BETOS-category fixed effects, and year fixed
effects. The variables log(price), log(income), and education are demeaned. Standard errors, shown in parentheses, are clustered
by the pre-1997 MPL.*10 percent level, **5 percent level, ***1 percent level.




                                                                    35
FOR ONLINE PUBLICATION ONLY
Appendix A: Mathematical Appendix

        We provide the detailed math accompanying propositions made in the paper. As laid out
in the paper, we make the following assumptions:
                                              ğ‘¢ğ‘¢â€²â€²â€² = 0, ğ‘§ğ‘§ â€²â€² = 0, ğ‘§ğ‘§ â€²â€²â€² = 0
                                                    ğ¹ğ¹â€²â€² < 0, ğ‘ğ‘â€²â€² > 0
                                                   ğ¹ğ¹â€²â€²â€² = 0, ğ‘ğ‘â€²â€²â€² = 0
                                         ğœğœğ‘‹ğ‘‹ > 0, ğœğœğ‘ƒğ‘ƒ > 0, ğœğœğ‘‹ğ‘‹ğ‘‹ğ‘‹ > 0, ğœğœğ‘‹ğ‘‹ğ‘‹ğ‘‹ = 0
Physicians maximize the following objective function:
                     max(1 âˆ’ ğ›¼ğ›¼)ğ‘§ğ‘§(ğ‘ƒğ‘ƒğ‘ƒğ‘ƒ âˆ’ ğ‘ğ‘(ğ‘‹ğ‘‹)) + ğ›¼ğ›¼ğ›¼ğ›¼(ğ¼ğ¼ + ğ‘£ğ‘£ğ‘£ğ‘£(ğ‘‹ğ‘‹) âˆ’ ğœ‹ğœ‹ âˆ’ ğœğœ(ğ‘‹ğ‘‹; ğ‘ƒğ‘ƒ))
                       ğ‘‹ğ‘‹

The first-order condition is:
                                 ğ›¼ğ›¼ğ‘¢ğ‘¢â€² âˆ— (ğ‘£ğ‘£ğ‘£ğ‘£â€² âˆ’ ğœğœğ‘‹ğ‘‹ ) + (1 âˆ’ ğ›¼ğ›¼)ğ‘§ğ‘§ â€² âˆ— (ğ‘ƒğ‘ƒ âˆ’ câ€²) = 0
The comparative static of price on utilization is given by:
           ğœ•ğœ•ğœ•ğœ• (âˆ’ğ›¼ğ›¼ğ‘¢ğ‘¢â€² ğœğœğ‘‹ğ‘‹ğ‘‹ğ‘‹ âˆ’ ğ›¼ğ›¼ğ‘¢ğ‘¢â€²â€² (ğ‘£ğ‘£ğ‘£ğ‘£â€² âˆ’ ğœğœğ‘‹ğ‘‹ )(ğœğœğ‘ƒğ‘ƒ ) + (1 âˆ’ ğ›¼ğ›¼)ğ‘§ğ‘§ â€² + (1 âˆ’ ğ›¼ğ›¼)ğ‘§ğ‘§ â€²â€² (ğ‘ƒğ‘ƒ âˆ’ ğ‘ğ‘â€²)ğ‘‹ğ‘‹)
                =                                                                                           ,
           ğœ•ğœ•ğœ•ğœ•                                              (âˆ’ğ·ğ·)
where ğ·ğ· â‰¡ ğ›¼ğ›¼ğ‘¢ğ‘¢â€²â€² (ğ‘£ğ‘£ğ‘£ğ‘£â€² âˆ’ ğœğœğ‘‹ğ‘‹ )2 + ğ›¼ğ›¼ğ‘¢ğ‘¢â€² (ğ‘£ğ‘£ğ‘£ğ‘£â€²â€²) + (1 âˆ’ ğ›¼ğ›¼)ğ‘§ğ‘§ â€²â€² (ğ‘ƒğ‘ƒ âˆ’ ğ‘ğ‘â€²)2 + (1 âˆ’ ğ›¼ğ›¼)ğ‘§ğ‘§ â€² (âˆ’ğ‘ğ‘â€²â€²) < 0. Below,
we prove Proposition 1 for when there is private over-use (case 1) and private under-use (case 2).

A.1. Case 1: Private Over-use: ğ’—ğ’—ğ’—ğ’—â€² âˆ’ ğˆğˆğ‘¿ğ‘¿ < ğŸğŸ

In the case of private over-use, the effect of income on utilization is positive because
                                    ğœ•ğœ•ğœ•ğœ• [ğ›¼ğ›¼ğ‘¢ğ‘¢â€²â€² (ğ‘£ğ‘£ğ‘£ğ‘£â€² âˆ’ ğœğœğ‘‹ğ‘‹ )]
                                          =                       >0
                                     ğœ•ğœ•ğœ•ğœ•         (âˆ’ğ·ğ·)
        Higher income results in higher medical care utilization. Next, we establish a few useful
lemmas in the case of private over-use.

USEFUL LEMMAS IN THE CASE OF PRIVATE OVER-USE
        Define:
           ğ‘ğ‘ğ‘ƒğ‘ƒ â‰¡ (âˆ’ğ›¼ğ›¼ğ‘¢ğ‘¢â€² ğœğœğ‘‹ğ‘‹ğ‘‹ğ‘‹ âˆ’ ğ›¼ğ›¼ğ‘¢ğ‘¢â€²â€² (ğ‘£ğ‘£ğ‘£ğ‘£â€² âˆ’ ğœğœğ‘‹ğ‘‹ )(ğœğœğ‘ƒğ‘ƒ ) + (1 âˆ’ ğ›¼ğ›¼)ğ‘§ğ‘§ â€² + (1 âˆ’ ğ›¼ğ›¼)ğ‘§ğ‘§ â€²â€² (ğ‘ƒğ‘ƒ âˆ’ ğ‘ğ‘â€²)ğ‘‹ğ‘‹)
                                               ğ‘ğ‘ğ¼ğ¼ â‰¡ [ğ›¼ğ›¼ğ‘¢ğ‘¢â€²â€² (ğ‘£ğ‘£ğ‘£ğ‘£â€² âˆ’ ğœğœğ‘‹ğ‘‹ )]

                       ğğ(âˆ’ğ‘«ğ‘«)
Lemma 1: Prove:                  > ğŸğŸ.
                        ğğğğ


                                                                 36
                   ğœ•ğœ•(âˆ’ğ·ğ·)
       Note that                   has the following four components:
                      ğœ•ğœ•ğœ•ğœ•

                   Î“11 â‰¡ âˆ’ğ›¼ğ›¼ğ‘¢ğ‘¢â€²â€²â€² (ğ‘£ğ‘£ğ‘£ğ‘£â€² âˆ’ ğœğœğ‘‹ğ‘‹ )3 âˆ’ ğ›¼ğ›¼ğ‘¢ğ‘¢â€²â€² 2(ğ‘£ğ‘£ğ‘£ğ‘£â€² âˆ’ ğœğœğ‘‹ğ‘‹ )(ğ‘£ğ‘£ğ‘£ğ‘£â€²â€² âˆ’ ğœğœğ‘‹ğ‘‹ğ‘‹ğ‘‹ ) > 0
       where this result follows because ğ‘¢ğ‘¢â€²â€²â€² â‰¥ 0, ğ‘¢ğ‘¢â€²â€² < 0, ğ¹ğ¹â€²â€² < 0, and ğœğœğ‘‹ğ‘‹ğ‘‹ğ‘‹ = 0.
                                     Î“21 â‰¡ âˆ’ğ›¼ğ›¼ğ‘¢ğ‘¢â€²â€² (ğ‘£ğ‘£ğ‘£ğ‘£â€²â€²)(ğ‘£ğ‘£ğ‘£ğ‘£â€² âˆ’ ğœğœğ‘‹ğ‘‹ ) âˆ’ ğ›¼ğ›¼ğ‘¢ğ‘¢â€² (ğ‘£ğ‘£ğ‘£ğ‘£â€²â€²â€²) > 0
       Where this result follows because ğ¹ğ¹ğ‘‹ğ‘‹ğ‘‹ğ‘‹ğ‘‹ğ‘‹ â‰¤ 0.
                       Î“31 â‰¡ âˆ’(1 âˆ’ ğ›¼ğ›¼)ğ‘§ğ‘§ â€²â€²â€² (ğ‘ƒğ‘ƒ âˆ’ ğ‘ğ‘ â€² )3 âˆ’ (1 âˆ’ ğ›¼ğ›¼)ğ‘§ğ‘§â€²â€²2(ğ‘ƒğ‘ƒ âˆ’ ğ‘ğ‘â€²)(âˆ’ğ‘ğ‘â€²â€²)
       This term disappears under physician risk-neutrality.
                                   Î“41 â‰¡ (1 âˆ’ ğ›¼ğ›¼)ğ‘§ğ‘§ â€²â€² (ğ‘ğ‘â€²â€²)(ğ‘ƒğ‘ƒ âˆ’ ğ‘ğ‘â€²) + (1 âˆ’ ğ›¼ğ›¼)ğ‘§ğ‘§ â€² (ğ‘ğ‘â€²â€²â€²) â‰¥ 0
       This result follows so long as ğ‘ğ‘â€²â€²â€² â‰¥ 0 and ğ‘§ğ‘§â€²â€² = 0. QED

                       ğğğ‘µğ‘µğ‘·ğ‘·
Lemma 2: Prove:                    < ğŸğŸ
                        ğğğğ
                   ğœ•ğœ•ğ‘ğ‘ğ‘ƒğ‘ƒ
       Note that              has the following four components:
                    ğœ•ğœ•ğœ•ğœ•

                                               Î“12 â‰¡ âˆ’ğ›¼ğ›¼ğ‘¢ğ‘¢â€²â€² ğœğœğ‘¥ğ‘¥ğ‘¥ğ‘¥ (ğ‘£ğ‘£ğ‘£ğ‘£â€² âˆ’ ğœğœğ‘‹ğ‘‹ ) < 0
       This result follows by our case assumption.
                                                       ğœ•ğœ•ï¿½âˆ’ğ›¼ğ›¼ğ‘¢ğ‘¢â€²â€² (ğ‘£ğ‘£ğ‘£ğ‘£â€² âˆ’ ğœğœğ‘‹ğ‘‹ )(ğœğœğ‘ƒğ‘ƒ )ï¿½
                                               Î“22 â‰¡
                                                                     ğœ•ğœ•ğœ•ğœ•
               = âˆ’ğ›¼ğ›¼ğ‘¢ğ‘¢â€²â€²â€² (ğ‘£ğ‘£ğ‘£ğ‘£â€² âˆ’ ğœğœğ‘‹ğ‘‹ )2 ğœğœğ‘ƒğ‘ƒ âˆ’ ğ›¼ğ›¼ğ‘¢ğ‘¢â€²â€² (ğ‘£ğ‘£ğ‘£ğ‘£â€²â€² âˆ’ ğœğœğ‘‹ğ‘‹ğ‘‹ğ‘‹ )(ğœğœğ‘ƒğ‘ƒ ) âˆ’ ğ›¼ğ›¼ğ‘¢ğ‘¢â€²â€² (ğ‘£ğ‘£ğ‘£ğ‘£â€² âˆ’ ğœğœğ‘‹ğ‘‹ )ğœğœğ‘ƒğ‘ƒğ‘ƒğ‘ƒ < 0
       This result follows so long as ğ‘¢ğ‘¢â€²â€²â€² â‰¥ 0.
                                                Î“32 â‰¡ (1 âˆ’ ğ›¼ğ›¼)ğ‘§ğ‘§ â€²â€² (ğ‘ƒğ‘ƒ âˆ’ ğ‘ğ‘â€²) â‰¤ 0
       This result follows so long as ğ‘§ğ‘§ â€²â€² â‰¤ 0.
                   Î“42 â‰¡ (1 âˆ’ ğ›¼ğ›¼)ğ‘§ğ‘§ â€²â€²â€² (ğ‘ƒğ‘ƒ âˆ’ ğ‘ğ‘â€²)2 ğ‘‹ğ‘‹ + (1 âˆ’ ğ›¼ğ›¼)ğ‘§ğ‘§ â€²â€² (ğ‘ƒğ‘ƒ âˆ’ ğ‘ğ‘â€² âˆ’ ğ‘ğ‘â€²â€²ğ‘‹ğ‘‹) = 0
       This follows because ğ‘§ğ‘§ â€²â€²â€² = 0, and ğ‘§ğ‘§ â€²â€² = 0. QED

                       ğğğ‘µğ‘µğ‘°ğ‘°
Lemma 3: Prove:                    > ğŸğŸ
                       ğğğğ
                   ğœ•ğœ•ğ‘ğ‘ğ¼ğ¼
       Note that             = ğ›¼ğ›¼ğ‘¢ğ‘¢â€²â€² (ğ‘£ğ‘£ğ‘£ğ‘£â€²â€² âˆ’ ğœğœğ‘‹ğ‘‹ğ‘‹ğ‘‹ ) + ğ›¼ğ›¼ğ‘¢ğ‘¢â€²â€²â€² (ğ‘£ğ‘£ğ‘£ğ‘£â€² âˆ’ ğœğœğ‘‹ğ‘‹ )2 > 0. This proves the result, because
                   ğœ•ğœ•ğœ•ğœ•

ğ¹ğ¹â€²â€² < 0 and ğ‘¢ğ‘¢â€²â€²â€² â‰¥ 0. QED

                     ğœ•ğœ•(âˆ’ğ·ğ·)
Lemma 4: Prove:                      <0
                            ğœ•ğœ•ğœ•ğœ•
                   ğœ•ğœ•(âˆ’ğ·ğ·)
       Note that       ğœ•ğœ•ğœ•ğœ•
                                    = âˆ’ğ›¼ğ›¼ğ‘¢ğ‘¢â€²â€²â€² (ğ‘£ğ‘£ğ‘£ğ‘£â€² âˆ’ ğœğœğ‘‹ğ‘‹ )2 âˆ’ ğ›¼ğ›¼ğ‘¢ğ‘¢â€²â€² (ğ‘£ğ‘£ğ‘£ğ‘£â€²â€²). Since ğ‘¢ğ‘¢â€²â€²â€² â‰¥ 0 and ğ¹ğ¹â€²â€² < 0, this term

is negative. QED

                                                                       37
                                      ğœ•ğœ•ğ‘ğ‘ğ‘ƒğ‘ƒ
Lemma 5: Prove:                                  >0
                                         ğœ•ğœ•ğœ•ğœ•
            ğœ•ğœ•ğ‘ğ‘ğ‘ƒğ‘ƒ
                         = âˆ’ğ›¼ğ›¼ğ‘¢ğ‘¢â€²â€² ğœğœğ‘‹ğ‘‹ğ‘‹ğ‘‹ âˆ’ ğ›¼ğ›¼ğ‘¢ğ‘¢â€²â€²â€² (ğ‘£ğ‘£ğ‘£ğ‘£â€² âˆ’ ğœğœğ‘‹ğ‘‹ )(ğœğœğ‘ƒğ‘ƒ ) > 0, because ğ‘¢ğ‘¢â€²â€² < 0 and ğ‘¢ğ‘¢â€²â€²â€² â‰¥ 0. QED
                ğœ•ğœ•ğœ•ğœ•


PROOF OF PROPOSITION 1 IN THE CASE OF PRIVATE OVER-USE
            We will now prove Proposition 1 for the private over-use case, or specifically: if ğ‘£ğ‘£ğ‘£ğ‘£â€² âˆ’
                          ğœ•ğœ•ğœ•ğœ•                      âˆ‚2 X                          âˆ‚2 X           âˆ‚2 X
ğœğœğ‘‹ğ‘‹ < 0 and ğœ•ğœ•ğœ•ğœ• > 0, then âˆ‚P âˆ‚Iï¿½                                 > 0 and âˆ‚P âˆ‚I < âˆ‚P âˆ‚Iï¿½ âˆ— .
                                                              Xâˆ—                                        X
                                                          ğœ•ğœ•ğ‘ğ‘ğ‘ƒğ‘ƒ        ğœ•ğœ•(âˆ’ğ·ğ·)
                                            âˆ‚2 X                 (âˆ’ğ·ğ·)âˆ’         (ğ‘ğ‘ğ‘ƒğ‘ƒ )                     ğœ•ğœ•ğ‘ğ‘ğ‘ƒğ‘ƒ                     ğœ•ğœ•(âˆ’ğ·ğ·)                                   ğœ•ğœ•ğœ•ğœ•
            For fixed ğ‘‹ğ‘‹, âˆ‚P âˆ‚I =                           ğœ•ğœ•ğœ•ğœ•
                                                                    (âˆ’ğ·ğ·)
                                                                           ğœ•ğœ•ğœ•ğœ•
                                                                           2
                                                                                      . Recall that                   > 0 and                          < 0, and when ğœ•ğœ•ğœ•ğœ• >
                                                                                                             ğœ•ğœ•ğœ•ğœ•                            ğœ•ğœ•ğœ•ğœ•

                                                                                   âˆ‚2 X
0, it implies that ğ‘ğ‘ğ‘ƒğ‘ƒ > 0. This proves that âˆ‚P âˆ‚Iï¿½                                             > 0.
                                                                                          Xâˆ—
                                                                                                                       ğœ•ğœ•ğœ•ğœ•
            Next, observe that the total change in the numerator of ğœ•ğœ•ğœ•ğœ• with respect to patient income is
                       ğœ•ğœ•ğ‘ğ‘ğ‘ƒğ‘ƒ ğœ•ğœ•ğœ•ğœ•       ğœ•ğœ•ğ‘ğ‘ğ‘ƒğ‘ƒ                     ğœ•ğœ•ğ‘ğ‘ğ‘ƒğ‘ƒ                ğœ•ğœ•ğœ•ğœ•                                         ğœ•ğœ•ğ‘ğ‘ğ‘ƒğ‘ƒ ğœ•ğœ•ğœ•ğœ•         ğœ•ğœ•ğ‘ğ‘ğ‘ƒğ‘ƒ             ğœ•ğœ•ğ‘ğ‘ğ‘ƒğ‘ƒ
given by:                            +            |ğ‘‹ğ‘‹ âˆ— . Since                < 0 and           > 0, it follows that                                  +            |ğ‘‹ğ‘‹ âˆ— <            ï¿½ .
                        ğœ•ğœ•ğœ•ğœ• ğœ•ğœ•ğœ•ğœ•         ğœ•ğœ•ğœ•ğœ•                       ğœ•ğœ•ğœ•ğœ•                 ğœ•ğœ•ğœ•ğœ•                                             ğœ•ğœ•ğœ•ğœ• ğœ•ğœ•ğœ•ğœ•        ğœ•ğœ•ğœ•ğœ•               ğœ•ğœ•ğœ•ğœ• ğ‘‹ğ‘‹ âˆ—

Similarly, the total change in the denominator with respect to patient income is given by:
ğœ•ğœ•(âˆ’ğ·ğ·) ğœ•ğœ•ğœ•ğœ•            ğœ•ğœ•(âˆ’ğ·ğ·)                   ğœ•ğœ•(âˆ’ğ·ğ·)               ğœ•ğœ•ğœ•ğœ•                                  ğœ•ğœ•(âˆ’ğ·ğ·)             ğœ•ğœ•(âˆ’ğ·ğ·)
                +                 . Since                  >0 and              > 0, it follows that                           >              ï¿½ âˆ— . QED
  ğœ•ğœ•ğœ•ğœ•   ğœ•ğœ•ğœ•ğœ•              ğœ•ğœ•ğœ•ğœ•                    ğœ•ğœ•ğœ•ğœ•                 ğœ•ğœ•ğœ•ğœ•                                        ğœ•ğœ•ğœ•ğœ•            ğœ•ğœ•ğ¼ğ¼       ğ‘‹ğ‘‹




A.2. Case 2: Private Under-use: ğ’—ğ’—ğ’—ğ’—â€² âˆ’ ğˆğˆğ‘¿ğ‘¿ > ğŸğŸ

In the case of private under-use, the effect of income on utilization is negative because:
                                    ğœ•ğœ•ğœ•ğœ• [ğ›¼ğ›¼ğ‘¢ğ‘¢â€²â€² (ğ‘£ğ‘£ğ‘£ğ‘£â€² âˆ’ ğœğœğ‘‹ğ‘‹ )]
                                         =                        <0
                                    ğœ•ğœ•ğœ•ğœ•          (âˆ’ğ·ğ·)
            Next, we establish some useful lemmas in the case of private under-use.

USEFUL LEMMAS IN THE CASE OF PRIVATE UNDER-USE
            Define:
                   ğ‘ğ‘ğ‘ƒğ‘ƒ â‰¡ (âˆ’ğ›¼ğ›¼ğ‘¢ğ‘¢â€² ğœğœğ‘‹ğ‘‹ğ‘‹ğ‘‹ âˆ’ ğ›¼ğ›¼ğ‘¢ğ‘¢â€²â€² (ğ‘£ğ‘£ğ‘£ğ‘£â€² âˆ’ ğœğœğ‘‹ğ‘‹ )(ğœğœğ‘ƒğ‘ƒ ) + (1 âˆ’ ğ›¼ğ›¼)ğ‘§ğ‘§ â€² + (1 âˆ’ ğ›¼ğ›¼)ğ‘§ğ‘§ â€²â€² (ğ‘ƒğ‘ƒ âˆ’ ğ‘ğ‘â€²)ğ‘‹ğ‘‹)
                                                                            ğ‘ğ‘ğ¼ğ¼ â‰¡ [ğ›¼ğ›¼ğ‘¢ğ‘¢â€²â€² (ğ‘£ğ‘£ğ‘£ğ‘£â€² âˆ’ ğœğœğ‘‹ğ‘‹ )]



                                      ğœ•ğœ•(âˆ’ğ·ğ·)
Lemma 6: Prove:                                    < 0.
                                          ğœ•ğœ•ğœ•ğœ•
                                     ğœ•ğœ•(âˆ’ğ·ğ·)
            Note that                             has the following four components:
                                      ğœ•ğœ•ğœ•ğœ•


                                                                                                  38
                       Î“11 â‰¡ âˆ’ğ›¼ğ›¼ğ‘¢ğ‘¢â€²â€²â€² (ğ‘£ğ‘£ğ¹ğ¹ â€² âˆ’ ğœğœğ‘‹ğ‘‹ )3 âˆ’ ğ›¼ğ›¼ğ‘¢ğ‘¢â€²â€² 2(ğ‘£ğ‘£ğ¹ğ¹ â€² âˆ’ ğœğœğ‘‹ğ‘‹ )(ğ‘£ğ‘£ğ¹ğ¹ â€²â€² âˆ’ ğœğœğ‘‹ğ‘‹ğ‘‹ğ‘‹ ) < 0,
where this result follows because ğ‘¢ğ‘¢â€²â€²â€² â‰¥ 0, ğ‘¢ğ‘¢â€²â€² < 0, ğ¹ğ¹â€²â€² < 0, and ğœğœğ‘‹ğ‘‹ğ‘‹ğ‘‹ = 0.
                                        Î“21 â‰¡ âˆ’ğ›¼ğ›¼ğ‘¢ğ‘¢â€²â€² (ğ‘£ğ‘£ğ¹ğ¹ â€²â€² )(ğ‘£ğ‘£ğ¹ğ¹ â€² âˆ’ ğœğœğ‘‹ğ‘‹ ) âˆ’ ğ›¼ğ›¼ğ‘¢ğ‘¢â€² (ğ‘£ğ‘£ğ¹ğ¹ â€²â€²â€² ) < 0,
where this result follows so long as ğ¹ğ¹â€²â€²â€² â‰¥ 0.
                       Î“31 â‰¡ âˆ’(1 âˆ’ ğ›¼ğ›¼)ğ‘§ğ‘§ â€²â€²â€² (ğ‘ƒğ‘ƒ âˆ’ ğ‘ğ‘â€²)3 âˆ’ (1 âˆ’ ğ›¼ğ›¼)ğ‘§ğ‘§ â€²â€² 2(ğ‘ƒğ‘ƒ âˆ’ ğ‘ğ‘â€²)(âˆ’ğ‘ğ‘â€²â€²) < 0
This result follows as long as ğ‘§ğ‘§ â€²â€²â€² = ğ‘§ğ‘§ â€²â€² = 0.
                                       Î“41 â‰¡ (1 âˆ’ ğ›¼ğ›¼)ğ‘§ğ‘§ â€²â€² (ğ‘ğ‘â€²â€²)(ğ‘ƒğ‘ƒ âˆ’ ğ‘ğ‘â€²) + (1 âˆ’ ğ›¼ğ›¼)ğ‘§ğ‘§ â€² (ğ‘ğ‘â€²â€²â€²) â‰¤ 0
This result follows so long as ğ‘ğ‘â€²â€²â€² â‰¤ 0. QED

                          ğœ•ğœ•ğ‘ğ‘ğ‘ƒğ‘ƒ
Lemma 7: Prove:                        >0
                           ğœ•ğœ•ğœ•ğœ•
                        ğœ•ğœ•ğ‘ğ‘ğ‘ƒğ‘ƒ
        Note that                 has the following four components:
                         ğœ•ğœ•ğœ•ğœ•

                                                   Î“12 â‰¡ âˆ’ğ›¼ğ›¼ğ‘¢ğ‘¢â€²â€² ğœğœğ‘¥ğ‘¥ğ‘¥ğ‘¥ (ğ‘£ğ‘£ğ‘£ğ‘£â€² âˆ’ ğœğœğ‘‹ğ‘‹ ) > 0
This result follows, so long as care is beneficial to consumers on the margin.
                                                           ğœ•ğœ•ï¿½âˆ’ğ›¼ğ›¼ğ‘¢ğ‘¢â€²â€² (ğ‘£ğ‘£ğ¹ğ¹ â€² âˆ’ ğœğœğ‘‹ğ‘‹ )(ğœğœğ‘ƒğ‘ƒ )ï¿½
                                                   Î“22 â‰¡
                                                                         ğœ•ğœ•ğœ•ğœ•
                     = âˆ’ğ›¼ğ›¼ğ‘¢ğ‘¢â€²â€²â€² (ğ‘£ğ‘£ğ‘£ğ‘£â€² âˆ’ ğœğœğ‘‹ğ‘‹ )2 ğœğœğ‘ƒğ‘ƒ âˆ’ ğ›¼ğ›¼ğ‘¢ğ‘¢â€²â€² (ğ‘£ğ‘£ğ‘£ğ‘£â€²â€² âˆ’ ğœğœğ‘‹ğ‘‹ğ‘‹ğ‘‹ )(ğœğœğ‘ƒğ‘ƒ ) âˆ’ ğ›¼ğ›¼ğ‘¢ğ‘¢â€²â€² (ğ‘£ğ‘£ğ‘£ğ‘£â€² âˆ’ ğœğœğ‘‹ğ‘‹ )ğœğœğ‘ƒğ‘ƒğ‘ƒğ‘ƒ > 0
Under our assumption that ğ‘¢ğ‘¢â€²â€²â€² â‰¤ 0, the result follows.
                                                    Î“32 â‰¡ (1 âˆ’ ğ›¼ğ›¼)ğ‘§ğ‘§ â€²â€² (ğ‘ƒğ‘ƒ âˆ’ ğ‘ğ‘â€²) â‰¥ 0
This result follows from ğ‘§ğ‘§ â€²â€² â‰¤ 0.
                        Î“42 â‰¡ (1 âˆ’ ğ›¼ğ›¼)ğ‘§ğ‘§ â€²â€²â€² (ğ‘ƒğ‘ƒ âˆ’ ğ‘ğ‘â€²)2 ğ‘‹ğ‘‹ + (1 âˆ’ ğ›¼ğ›¼)ğ‘§ğ‘§ â€²â€² (ğ‘ƒğ‘ƒ âˆ’ ğ‘ğ‘â€² âˆ’ ğ‘ğ‘â€²â€²ğ‘‹ğ‘‹) > 0
This follows because ğ‘§ğ‘§ â€²â€²â€² â‰¥ 0, and ğ‘§ğ‘§ â€²â€² â‰¤ 0. QED

                          ğœ•ğœ•ğ‘ğ‘ğ¼ğ¼
Lemma 8: Prove:                        >0
                          ğœ•ğœ•ğœ•ğœ•
                       ğœ•ğœ•ğ‘ğ‘ğ¼ğ¼
        Note that                = ğ›¼ğ›¼ğ‘¢ğ‘¢â€²â€² (ğ‘£ğ‘£ğ‘£ğ‘£â€²â€² âˆ’ ğœğœğ‘‹ğ‘‹ğ‘‹ğ‘‹ ) + ğ›¼ğ›¼ğ‘¢ğ‘¢â€²â€²â€² (ğ‘£ğ‘£ğ‘£ğ‘£â€² âˆ’ ğœğœğ‘‹ğ‘‹ )2 > 0. This proves the result, because
                        ğœ•ğœ•ğœ•ğœ•

ğ¹ğ¹â€²â€² â‰¤ 0 and ğ‘¢ğ‘¢â€²â€²â€² â‰¥ 0. QED

                          ğœ•ğœ•(âˆ’ğ·ğ·)
Lemma 9: Prove:                          <0
                                ğœ•ğœ•ğœ•ğœ•
            ğœ•ğœ•(âˆ’ğ·ğ·)
Note that     ğœ•ğœ•ğœ•ğœ•
                       = âˆ’ğ›¼ğ›¼ğ‘¢ğ‘¢â€²â€²â€² (ğ‘£ğ‘£ğ‘£ğ‘£â€² âˆ’ ğœğœğ‘‹ğ‘‹ )2 âˆ’ ğ›¼ğ›¼ğ‘¢ğ‘¢â€²â€² (ğ‘£ğ‘£ğ‘£ğ‘£â€²â€²). Since ğ‘¢ğ‘¢â€²â€²â€² â‰¥ 0 and ğ¹ğ¹â€²â€² < 0, this term is

negative. QED



                                                                           39
                                         ğœ•ğœ•ğ‘ğ‘ğ‘ƒğ‘ƒ
Lemma 10: Prove:                                  >0
                                           ğœ•ğœ•ğœ•ğœ•
            ğœ•ğœ•ğ‘ğ‘ğ‘ƒğ‘ƒ
                         = âˆ’ğ›¼ğ›¼ğ‘¢ğ‘¢â€²â€² ğœğœğ‘‹ğ‘‹ğ‘‹ğ‘‹ âˆ’ ğ›¼ğ›¼ğ‘¢ğ‘¢â€²â€²â€² (ğ‘£ğ‘£ğ‘£ğ‘£â€² âˆ’ ğœğœğ‘‹ğ‘‹ )(ğœğœğ‘ƒğ‘ƒ ) > 0. This result follows if ğ‘¢ğ‘¢â€²â€²â€² = 0. QED
                ğœ•ğœ•ğœ•ğœ•


PROOF OF PROPOSITION 1 IN THE CASE OF PRIVATE UNDER-USE
            We will now prove Proposition 1 for the private under-use case, or specifically: If ğ‘£ğ‘£ğ‘£ğ‘£â€² âˆ’
                          ğœ•ğœ•ğœ•ğœ•                                âˆ‚2 X                        âˆ‚2 X         âˆ‚2 X
ğœğœğ‘‹ğ‘‹ > 0 and ğœ•ğœ•ğœ•ğœ• > 0, then then âˆ‚P âˆ‚Iï¿½                                       > 0 and âˆ‚P âˆ‚I < âˆ‚P âˆ‚Iï¿½ âˆ— .
                                                                      ğ‘‹ğ‘‹ âˆ—                                     ğ‘‹ğ‘‹
                                                          ğœ•ğœ•ğ‘ğ‘ğ‘ƒğ‘ƒ        ğœ•ğœ•(âˆ’ğ·ğ·)
                                           âˆ‚2 X                  (âˆ’ğ·ğ·)âˆ’         (ğ‘ğ‘ğ‘ƒğ‘ƒ )                   ğœ•ğœ•ğ‘ğ‘ğ‘ƒğ‘ƒ                        ğœ•ğœ•(âˆ’ğ·ğ·)                                   ğœ•ğœ•ğœ•ğœ•
            For fixed ğ‘‹ğ‘‹, âˆ‚P âˆ‚I =                           ğœ•ğœ•ğœ•ğœ•
                                                                    (âˆ’ğ·ğ·)
                                                                           ğœ•ğœ•ğœ•ğœ•
                                                                           2
                                                                                      . Recall that                    > 0 and                          < 0, and when ğœ•ğœ•ğœ•ğœ• >
                                                                                                              ğœ•ğœ•ğœ•ğœ•                            ğœ•ğœ•ğœ•ğœ•

                                                                                   âˆ‚2 X
0, it implies that ğ‘ğ‘ğ‘ƒğ‘ƒ > 0. This proves that âˆ‚P âˆ‚I                                            > 0.
                                                                                          Xâˆ—
                                                                                                                        ğœ•ğœ•ğœ•ğœ•
            Next, observe that the total change in the numerator of ğœ•ğœ•ğœ•ğœ• with respect to patient income is
                       ğœ•ğœ•ğ‘ğ‘ğ‘ƒğ‘ƒ ğœ•ğœ•ğœ•ğœ•       ğœ•ğœ•ğ‘ğ‘ğ‘ƒğ‘ƒ                      ğœ•ğœ•ğ‘ğ‘ğ‘ƒğ‘ƒ               ğœ•ğœ•ğœ•ğœ•                                          ğœ•ğœ•ğ‘ğ‘ğ‘ƒğ‘ƒ ğœ•ğœ•ğœ•ğœ•         ğœ•ğœ•ğ‘ğ‘ğ‘ƒğ‘ƒ             ğœ•ğœ•ğ‘ğ‘ğ‘ƒğ‘ƒ
given by:                            +            |ğ‘‹ğ‘‹ âˆ— . Since                 > 0 and           < 0, it follows that                                  +            |ğ‘‹ğ‘‹ âˆ— <            ï¿½ .
                        ğœ•ğœ•ğœ•ğœ• ğœ•ğœ•ğœ•ğœ•         ğœ•ğœ•ğœ•ğœ•                        ğœ•ğœ•ğœ•ğœ•                 ğœ•ğœ•ğœ•ğœ•                                             ğœ•ğœ•ğœ•ğœ• ğœ•ğœ•ğœ•ğœ•        ğœ•ğœ•ğœ•ğœ•               ğœ•ğœ•ğœ•ğœ• ğ‘‹ğ‘‹ âˆ—

Similarly, the total change in the denominator with respect to patient income is given by:
ğœ•ğœ•(âˆ’ğ·ğ·) ğœ•ğœ•ğœ•ğœ•            ğœ•ğœ•(âˆ’ğ·ğ·)                   ğœ•ğœ•(âˆ’ğ·ğ·)               ğœ•ğœ•ğœ•ğœ•                                   ğœ•ğœ•(âˆ’ğ·ğ·)             ğœ•ğœ•(âˆ’ğ·ğ·)
                +                 . Since                  <0 and               < 0, it follows that                           >              ï¿½ âˆ— . QED
  ğœ•ğœ•ğœ•ğœ•   ğœ•ğœ•ğœ•ğœ•              ğœ•ğœ•ğœ•ğœ•                    ğœ•ğœ•ğœ•ğœ•                  ğœ•ğœ•ğœ•ğœ•                                        ğœ•ğœ•ğœ•ğœ•            ğœ•ğœ•ğœ•ğœ•       ğ‘‹ğ‘‹




                                                                                                  40
Appendix B: Empirical Appendix

       In this section, we further illustrate the distribution of price variation from our GAF and
PE-RVU instruments, shown in Figures B1 and B2, and we discuss the remaining policy changes
during 1992 to 2003 that affected Medicare payments. We also document our construction of the
health variables.

Variation in Medicare Payments

       Other than the GAF and PE-RVU components detailed in Section 3.2, variation in
Medicare payments come from changes in the work RVU, malpractice RVU, and CF. On average,
work RVUs, PE-RVUs, and malpractice RVUs account for 52 percent, 44 percent, and 4 percent
of total payments, respectively (US Government Accountability Office, 2005). Because the
malpractice component accounts for such a small share of payments, we do not focus on it.
       From 1993 to 2002, work RVUs experienced two major reviews which became effective
in 1997 and 2002. Plot (a) of Figure B3 shows the average work RVU over time for HCPCS. After
the RUC committee met to re-assess work RVUs, we see clear jumps in the RVU. However, with
competing political pressures and physician incentives, it is unlikely that RUC committee changes
are exogenous to local demand and supply factors.
       The change in methodology for determining practice expense RVUs (PE-RVUs) from a
charge-based method to a resource-based system was enacted by the Balance Budget Act of 1997.
In developing the resource-based system, CMS considered the staff equipment and supplies used
in providing medical and surgical services in various settings (Federal Register 1999). A new set
of RVUs were proposed in June 1997 and subsequently adjusted following the review of
approximately 8,600 comments from providers and professional associations and societies. From
1999 to 2002, the new PE-RVU system was phased in as follows: in 1999 PE-RVUs were
calculated as a product of 75% of the previous charge-based PE-RVUs and 25% of the resource-
based PE-RVU system. In 2000, the percentages were 50% of the charge-based system and 50%
of the resource-based system. In 2001, the percentages were 25% of the charge-based system and
75% of the resource-based system. By 2002, PE-RVUs were based totally on resource-based
expenses.



                                                    41
       The CF also experienced a major change during our study period. Prior to 1998, there were
three different CFs: one for surgery, primary care, and non-surgical services. The CF for surgical
procedures led to surgeons earning a 17 percent bonus payment relative to all other procedures.
This generated political discontent and led to a budget-neutral merger of CFs in 1998 (Clemens
and Gottlieb, 2013). Plot (b) shows the CFs over time. After 1998, the CF for surgical procedures
fell by about 11 percent, whereas the CF for non-surgical procedures increased by about 6 percent.
We do not use this policy shock as another instrument for two reasons. First, CFs are constant
across all geographic regions and all procedures, so their explanatory power for payment changes
within physicians is weak. Second, the shock in CF payments occurs mainly for surgical
procedures, while changes in CF for non-surgical and primary care procedures are much less
pronounced.

Construction of Health Variables

       Measures of underlying health are extracted from claims and survey data. From the claims
data, we calculate the Charlson Comorbidity Index, which reflects the cumulative increase in
likelihood of one-year mortality due to the severity of comorbidities (Quan et al. 2005). (Quan et
al. 2005) From the survey data, we utilize self-reported metrics of height and weight to calculate
body mass index. We also created eight indicator variables for:
   â€¢   Broken hip, which equals one if the individual has had a broken hip within the last year.

   â€¢   Cancer, which equals one if the individual has any of the following cancers: bladder,

       breast, cervical, colon, head, kidney, lung, ovarian, prostate, stomach, throat, uterine or

       other cancer.

   â€¢   Diabetes, which equals one if the individual has diabetes.

   â€¢   Heart disease, which equals one if the individual has coronary heart disease, a myocardial

       infarction, or other heart conditions.

   â€¢   Hypertension, which equals one if the individual has hypertension.

   â€¢   Lung disease, which equals one if the individual has asthma, chronic obstructive

       pulmonary disease, or emphysema.

                                                    42
â€¢   Neurological disease, which equals one if the individual has Alzheimerâ€™s, Parkinsonâ€™s, a

    stroke, or other psychiatric condition (but excluding mental retardation).

â€¢   Some difficulty in physical functioning, which equals one if the individual has some or

    more difficulty in executing at least one of five activities: stooping or crouching; lifting

    or carrying objects of up to 10 pounds, extending arms above the shoulder; grasping

    small objects; and walking two or three blocks.




                                                  43
                            FIGURE B1: PRACTICE EXPENSE RVU BY FACILITY




         Notes: Data from the Federal Register 1992-2003. The top line shows changes in the facility PE-RVU. The bottom line
shows changes in the non-facility PE-RVU. Sample restricted to HCPCS observed in all years.




                                                                 44
                 FIGURE B2: DISTRIBUTION OF INSTRUMENT-INDUCED PRICE SHOCKS
                                    (a) Price Shock from GAF-Consolidation




                           (b) Price Shock from PE-RVU Methodology Change




          Notes: Data from the Federal Register and MCBS at the physician-patient-year level. Plot (a) shows the distribution of
the GAF-induced price change from 1996 to 1997. Plot (b) shows the distribution of PE-RVU induced price changes for physician
baskets of goods from 1998 to 2002.




                                                                   45
                     FIGURE B3: PERCENT CHANGE IN PE-RVU ACROSS HCPCS




        Notes: Data from the Federal Register and MCBS. For each HCPCS, we calculate the aggregate percent change in
PE-RVU from 1998 to 2002. The histogram of changes across procedures are shown.




                                                              46
                     FIGURE B4: REMAINING VARIATION IN MEDICARE PAYMENTS
                                       (a) Average Work RVU over Time




                                                 (b) Conversion Factor




         Notes: Data from Federal Register 1992-2003. Plot (a) show the change in work-RVUs. Evident from the graph are the
two major reviews by the RUC committee in 1997 and 2002. The sample is restricted to HCPCS observed in all years. Plot (b)
shows the change from three CFs (primary care, surgical, and non-surgical) to a single budget-neutral CF in 1998.




                                                                47
